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GLOSSARY OF ABBREVIATIONS AND ACRONYMS 
ACCORD Action to control cardiovascular risk in type 2 Diabetes 
AGE Advanced glycation end products 
BP Blood pressure 
CCD Charge-coupled device 
CFRT Central foveal retinal thickness 
CHEDV Centro Hospitalar Entre o Douro e o Vouga 
ChS Choriocapillaris/Sattler 
CL Choroidal layers 
CME Cystoid macular edema 
CRF Case Report Form 
CSME Clinically significant macular edema 
CT Choroidal Thickness 
DME Diabetic macular edema 
DO Drop out 
DR Diabetic Retinopathy 
DRIL Disorganization of retinal inner layers 
EDI Enhanced depth imaging 
ETDRS Early Treatment Diabetic Retinopathy Study 
FD Fourier domain 
IRMA Intraretinal microvascular abnormalities 
LFU Lost of follow up 
ME Macular edema 
MIT Massachusetts Institute of Technology 
NDR No diabetic retinopathy 
NPDR Non-proliferative diabetic retinopathy 
NSD Neurosensorial Detachment 
NVD New vessels on the disc 
NVE New vessels elsewhere 
OCT Optical Coherence Tomography 
OD Oculus dextrus — right eye 
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OP Ocular pressure 
OS Oculus sinister — left eye 
PDR Proliferative diabetic retinopathy 
PKC Protein Kinase C 
RPE Retinal Pigment Epithelium 
RT Retinal Thickness 
SCI Sclero-choroidal interface 
SD  Standard deviation 
SD-OCT Spectral Domain Optical Coherence Tomography 
SFCT Sub foveal choroidal thickness 
SLD Super Luminescent diode 
SMD Sub macular detachment 
SS-OCT Swept Source Optical Coherence Tomography 
TD-OCT Time Domain Optical Coherence Tomography 
UKPDS United Kingdom Prospective Diabetes Study 
VA Visual Acuity 
VEGF Vascular endothelial growth factor 
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CHOROIDAL THICKNESS AND MORPHOLOGY ANALYSED BY OPTICAL 
COHERENCE TOMOGRAPHY AS A METHOD TO APPROACH DIABETIC 
OCULAR DISEASE PROGNOSIS AND PROGRESSION 
INTRODUCTION 
Clinical evidence of diabetic choroidopathy (DC) in-vivo has been difficult to 
demonstrate clinically due to the lack of means to visualize the choroid. Advances of 
Optical Coherence Tomography (OCT) technology allowed in-vivo visualization of 
the choroid. Controversial results in Diabetes for choroidal thickness (CT) and lack 
in the identification of morphologic changes makes DC identified with OCT still to be 
understood. 
PURPOSE 
To evaluate whether CT measurement alone is a reliable parameter to characterize 
DC, to characterize choroidal morphological findings using the OCT and correlation 
with CT and the diabetic retinopathy (DR). 
METHODS 
A cohort, prospective, longitudinal and observational study, where diabetic and 
healthy controls were followed in consecutive visits. Inclusion criteria were: healthy 
CHOROIDAL THICKNESS AND MORPHOLOGY ANALYSED BY OPTICAL COHERENCE TOMOGRAPHY AS A 




and Diabetic patients without or with any stage of DR, aged 18 or more, signed 
voluntarily informed consent. Exclusion criteria were: previous treatment of any kind 
for DR; previous or ongoing ocular disease or history of ocular surgery; relevant 
media opacities; refractive errors greater than ± 6 Diopters; systemic chronic steroid 
or immunosuppressive medication; any serious and uncontrolled systemic condition. 
Previous studies were performed to identify choroidal morphological findings on OCT 
to be used as classification method. Quantitative assessment of retinal and 
subfoveal choroidal thickness (SFCT), qualitative assessment of choroidal 
morphological findings, and correlation with the retinal diabetic disease state. 
Evaluation of progression and predictive relevancy. 
RESULTS 
One hundred and ninety-six diabetic eyes and seventy-eight healthy eyes were 
included. From choroidal morphologic analysis we found: on healthy 78% were 
normal, and abnormalities found were always on the great vessels layers with 
preserved choriocapillaris/Sattler (ChS) layers. Most of diabetic eyes with no 
abnormalities had no and initial stages of DR. Focal choroidal vascular changes were 
correlated with the subjacent retinal disease. Atrophy of the ChS layer or the great 
vessels layer was well corelated with more advanced stages of DR and maculopathy. 
Progression of choroidal morphologic changes was well evidenced and correlated 
with progression of retinal disease. From statistical analysis: SFCT showed huge 
variability with multifactorial dependence. Statistical significance of correlation with 
SFCT was found only for age for both groups and choroidal layers abnormalities for 
diabetics and systolic blood pressure for healthy. 
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SFCT showed to be dependent on multifactorial variables with a wide range of values 
showing not to be a reliable parameter alone for DC evaluation. With OCT images 
we can identify and classify as normal or abnormal choroidal morphologic findings. 
Abnormal choroidal findings are well correlated with suprajacent retinal diabetic 
disease and can be a marker of evolution or progression of the disease of treatment 
effect. 
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ESPESOR COROIDEO Y MORFOLOGÍA ANALIZADO POR TOMOGRAFÍA DE 
COHERENCIA ÓPTICA COMO MÉTODO PARA ABORDAR LA PROGNOSIS Y LA 
PROGRESIÓN DE LA ENFERMEDAD OCULAR DIABÉTICA 
INTRODUCCIÓN 
La evidencia clínica in vivo de coroidopatía diabética (DC) ha sido difícil de 
demostrar clínicamente debido a la falta de medios para visualizar la coroides. Los 
avances de la tecnología de la tomografía de coherencia óptica (OCT) permitieron 
la visualización in vivo de la coroides. Los resultados controvertidos en la Diabetes 
para el grosor coroideo (CT) y la falta de identificación de los cambios morfológicos 
hacen que la DC identificada con OCT aún no se conozca. 
PROPÓSITO 
Evaluar si la medición por CT sola es un parámetro confiable para caracterizar la 
DC, para caracterizar los hallazgos morfológicos coroidales usando la OCT y la 
correlación con la CT y la retinopatía diabética (DR). 
MÉTODOS 
Estudio cohorte, prospectivo, longitudinal y observacional, donde se siguieron los 
controles diabéticos y sanos en visitas consecutivas. Los criterios de inclusión 
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fueron: pacientes sanos y diabéticos sin o con cualquier estadio de RD, de 18 años 
o más, firmados voluntariamente con consentimiento informado. Los criterios de 
exclusión fueron: tratamiento previo de cualquier tipo para DR; enfermedad ocular 
previa o en curso o antecedentes de cirugía ocular; opacidades de medios 
relevantes; errores de refracción mayores que ± 6 dioptrías; medicamentos séricos 
crónicos o inmunosupresores sistémicos; cualquier condición sistémica grave e 
incontrolada. Se realizaron estudios previos para identificar los hallazgos 
morfológicos de la coroides en OCT que se utilizarán como método de clasificación. 
Evaluación cuantitativa del grosor de la coroides retiniana y subfoveal (SFCT), 
evaluación cualitativa de los hallazgos morfológicos coroidales y correlación con el 
estado de la enfermedad diabética retiniana. Evaluación de progresión y relevancia 
predictiva. 
RESULTADOS 
Se incluyeron 96 ojos diabéticos y setenta y ocho ojos sanos. A partir del análisis 
morfológico de la coroides, encontramos que el 78% de los sanos eran normales y 
las anormalidades encontradas siempre en las capas de grandes vasos con capas 
preservadas de coriocapilar / Sattler (ChS). La mayoría de los ojos diabéticos sin 
anomalías no tenían y las etapas iniciales de DR. Los cambios vasculares coroidales 
focales se correlacionaron con la enfermedad retiniana subyacente. La atrofia de la 
capa de ChS o la capa de grandes vasos estaba bien correlacionada con etapas 
más avanzadas de DR y maculopatía. La progresión de los cambios morfológicos 
coroidales se evidenció y se correlacionó con la progresión de la enfermedad 
retiniana. A partir del análisis estadístico: SFCT mostró una gran variabilidad con la 
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dependencia multifactorial. La significación estadística de la correlación con SFCT 
se encontró solo para la edad para ambos grupos y las anomalías de las capas 
coroideas para los diabéticos y la presión arterial sistólica para la salud. 
CONCLUSIÓN 
SFCT mostró ser dependiente de variables multifactoriales con una amplia gama de 
valores que muestran que no es un parámetro confiable solo para la evaluación de 
DC. Con las imágenes de OCT podemos identificar y clasificar como hallazgos 
morfológicos coroidales normales o anormales. Los hallazgos anormales de la 
coroides están bien correlacionados con la enfermedad diabética retiniana 
suprayacente y pueden ser un marcador de evolución o progresión de la 
enfermedad del efecto del tratamiento. 
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CHAPTER 1 — INTRODUCTION 
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1 — INTRODUCTION 
Diabetes Mellitus has been increasing in prevalence over the last decades. 
According to the last report by the International Diabetes Federation, there were 425 
million diabetic patients in the adult population worldwide in 2017. This number 
projected to the year of 2045 will arise to 629 million1. Due to this epidemic 
prevalence of Diabetes, the World Health Organization emphasized on the World 
Health Day of 2016 the need to increase awareness on Diabetes and its morbidity 
and burden, and to stablish specific and effective actions to tackle Diabetes.2 
Diabetes is a metabolic disease associated to hyperglycemia. Severe acute or 
prolonged hyperglycemia leads to the macrovascular and microvascular diabetic 
disease affecting several organs and tissues. Microvascular complications are 
responsible for the diabetic nephropathy, neuropathy and retinopathy, while 
macrovascular complications affect mostly the heart and peripheral vascular 
systems and can be associated with stroke3. It is important to understand the 
pathophysiology of vascular damage due to hyperglycemia and the changes in 
vessels so that we can look for signs of risk to progression and ways to prevent 
and/or treat the vascular complications, such as in Diabetic retinopathy. 
According to a large systematic analysis, Diabetic retinopathy was responsible for 
1.9% of moderate to severe visual impairment globally and 2.6% of blindness in 
20104. Another meta-analysis demonstrated a worrying increase from 1990 to 2010 
of 27% in blindness and 64% of moderate to severe visual impairment due to 
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Diabetic retinopathy5. Higher risk and prevalence were found in older populations 
and high-income regions, such as Western Europe, North America and Australasia5. 
Diabetic retinopathy was first described by Eduard Jäger, in 1856, as a finding with 
the new ophthalmology instrument developed just few years earlier, the 
opthalmoscope.6–8 Acceptance of a specific pattern of diabetic lesions in the retina 
only came on the 40’s with Ballantyne’s description9 and later with Ashton and 
Cogan.7,9–11 In the 60’s, the publication of the new technique fluorescein angiography 
and its progressive use in ophthalmology, brought about new insights into the 
pathophysiology of diabetic retinopathy and allowed new advances in diagnosis and 
treatment guidelines.12,13 
For about 3 decades, the only ophthalmic imaging systems available for examination 
and diagnosis were fundus photography and angiography. In the early 90’s David 
Huang presents a paper on the Optical Coherence Tomography.14 It was a 
breakthrough in Ophthalmology and in the diagnosis, treatment and follow up for 
ocular diseases, with special focus on retinal diseases.  Since the initial 
development, commercialization of the first device for clinical purpose till now, the 
Optical Coherence Tomography (OCT) systems have been improving in acquisition 
systems, hardware and software for better resolution, increased speed and 
increased information.15,16 The OCT has allowed, with a noninvasive 
ophthalmological exam, to have qualitative and quantitative information of the retina, 
with anatomical and in-depth information. It has also been very important in the 
workup of Diabetic retinopathy, in the diagnosis and classification of macular edema, 
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in guiding treatment indications, efficacy and follow up, decreasing the need of the 
invasive ophthalmological exams, such as fluorescein angiography. 
The first OCTs, due to a limitation of the system, were unable to give information of 
deeper structures such the choroid. In 2008 Spaide et al. described a novel imaging 
technique using the OCT Spectralis system that allowed to improve choroidal 
visualization, the Enhanced Depth Imaging (EDI).17,18 Since then with the evolution 
of the OCT systems with increased acquisition speed, increased resolution and the 
availability of the Swept-Source OCT, choroidal visualization has been improved. 
New data from retinal and choroidal diseases have emerged with this additional 
feature of the OCTs. 
Since the first publication by Spaide describing the EDI, several papers have been 
published regarding choroidal thickness and its correlation with retinal disease. 
Several look for a correlation of choroidal thickness changes with the diabetic 
retinopathy trying to find signs of a diabetic choroidopathy. The results between the 
papers vary and sometimes are controversial. 
In this Section a review of current data was presented as the base for the rationale 
for this study. 
1.1. VASCULAR COMPLICATIONS OF DIABETES 
Diabetes and hyperglycemia cause disease in several tissues by affecting the 
vascular system. Great vessels and smaller/microscopic vessels affected by 
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hyperglycemia injury lead to two separated diabetic vascular disease: the 
macrovascular and the microvascular diabetic complications. 
It is important to understand how vascular complications occur, since the 
pathophysiology of diabetic retinopathy undergoes from them. The choroid is a 
mainly vascular structure, so it is expectable to have a diabetic choroidal vascular 
disease leading to a diabetic choroidopathy. 
Macrovascular diabetic disease affects primarily greater vessels with atherosclerotic 
process and hypercoagulation states increasing the risk of thrombosis, vessel 
occlusion and stroke. The exact mechanism how Diabetes increases the risk of 
atheroma formation is not well understood. Several studies had shown the 
association of Diabetes with an increased risk of cardiovascular disorders.3,19–24 
Type 2 Diabetes is a complex metabolic clinical condition that comes with increased 
blood glycose, hypertension, overweight, dyslipidemia, all of these contributing to a 
higher risk of cardiovascular disorder. So, the association of Diabetes with 
cardiovascular disorder seems to be a part of a multifactorial condition. 
Nevertheless, intensive control of blood pressure and lipid levels in Diabetic patients 
have shown a decrease in cardiovascular events.22,24–26 In type 1 Diabetic patients, 
usually thinner, younger with less propensity to high blood pressure or dyslipidemia, 
hyperglycemia was correlated to higher heart rate, a risk factor for cardiovascular 
disease.3,21,26 Macrovascular diabetic disease is associated to increased death risk. 
Microvascular diabetic disease tends to cause intrinsic damage on the anatomy and 
function of the affected organs. It refers to the disease affecting vessels with an 
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internal diameter of 100 or less microns. The most important manifestations of 
diabetic microvascular disease are the Diabetic retinopathy, nephropathy and 
neuropathy, being the retinopathy the most common complication. Microvascular 
disease in Diabetes occurs due to a particular vessel cellular response and damage 
caused by increased and sustained hyperglycemia.27–29 Although several studies 
demonstrate that hyperglycemia is a major risk factor for microvascular damage in 
Diabetes, other causes underly such concomitant pathologies (e.g. hypertension and 
dyslipidemia) and genetic predisposition30–32. 
Microvascular disease includes endothelial dysfunction, pericytes or podocytes 
death, increased vascular permeability and angiogenesis, basement membrane 
thickening, cell growth and apoptosis, vascular occlusion and dilatation, extracellular 
matrix expansion and dysfunctional enzymatic activity. From the increased metabolic 
products of the glycolytic pathway in hyperglycemic state, modulated by genetic 
predisposition and local tissue response, several mechanisms are involved into the 
microvascular lesion: the activation of specific enzymes, such as the protein kinase 
C (PKC), phospholipase, adenosine triphosphatase and others, leads to altered cell 
signaling or molecule transduction; the activation of the polyol pathway, the 
formation of advanced glycation end products (AGE) and the production of 
superoxide and reactive oxygen species, leads to oxidative and endoplasmic 
reticulum stress, and the increase in inflamatory cytokines. All of these changes 
cause abnormal turnover and vascular and cell dysfunction leading to the diabetic 
retinopathy, neuropathy and nephropathy.27,33,34 
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1.2. THE DIABETIC RETINOPATHY — A VASCULAR DISEASE 
Since the earliest description of diabetic retinopathy with ophthalmoscopy we have 
been able to identify vascular involvement of the diabetic disease by observing 
microaneurysms (small capillaries dilatations), intra-retinal hemorrhages, signs of 
exudation, vessel abnormalities and new-vessels. Fluorescein Angiography allows 
us to observe the anatomical and dynamic (flow and perfusion) changes in the 
vascular retina occurring in the diabetic disease. Optical coherence tomography 
demonstrates the presence of anatomical and thickness changes as the result of 
permeability alterations with fluid accumulation, cysts, and chronic sequalae as 
atrophy and loss of tissue and fibrosis. The classification of diabetic retinopathy has 
been evolving since the first, the Arlie House classification, to more simplified 
classifications such as the International Clinical Disease Severity Scale for Diabetic 
Retinopathy. The severity of the diabetic retinopathy is classified according to the 
extent of the vascular changes encountered.35–38 
Klein et al. described as earliest changes observed in diabetic retinopathy the 
widening of retinal venules, even before the appearance of microaneurysms and blot 
hemorrages.39 In a most recent review it is summarized how retinal microvasculature 
measured and quantified can indicate the risk of progression of diabetic retinal 
disease in pre-clinical stages.40 At the early clinical stages of diabetic retinopathy 
where findings are essentially microaneurysms, the turnover (or rate of appearance 
and disappearance) and count over time of the microaneurysms are biomarkers of 
disease progression.41–46 Also the turnover of microaneurysms and presence of 
foveal avascular zone abnormalities were described as characteristics allowing to 
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determine patterns or phenotypes of risk of progression to a more advanced 
disease.47–49 As the diabetic retinopathy progresses to more advanced stages, signs 
of alteration of the blood-retinal barrier permeability appear with more extensive 
retinal hemorrhages, hard exudates (representing lipidic deposition in the 
extravascular retinal space as a consequence of the lipoprotein leakage from the 
vessels), leakage and edema. More extensive vascular lesion can be observed with 
anatomical changes such as tortuosity, beading, loops, and infarction of the nerve 
fiber layer appearing as whitish or cotton wool spots. In severe or proliferative stages 
non-perfusion/ ischemia leads to neovascularization in the superficial retina with high 
risk of bleeding to the vitreous. Although some authors claim retinal 
neurodegenerative diabetic changes, it is not clear if they precede microvascular 
disease or are a consequence.50–54 It remains that the most important changes 
occurring in the retina and responsible for the morbidity and visual function disability 
are related to the vascular disease. 
Hyperglycemia is the trigger in Diabetes for the development of diabetic retinopathy. 
As previously described it leads by several biochemical, cellular, physiological and 
inflamatory mechanisms to vascular changes as the pericyte loss, endothelial cells 
damage, basement membrane thickening, capillary occlusion, blood-retinal barrier 
disfunction and increased permeability, increased circulating growth factors and 
oxidative products. However other concomitant conditions can act as incrementing 
risk factors for the microvascular disease, such as hypertension, dyslipidemia and 
genetics. The UKPDS showed benefit and decrease in the risk of progression of 
diabetic retinopathy in lowering blood pressure in uncontrolled hypertension.22 But 
the ACCORD did not find any benefit in lowering blood pressure in mild hypertensive 
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or normotensive patients in order to prevent diabetic retinopathy progression.55 
Some studies suggest that the control of lipid serum levels might have a small effect 
on diabetic retinopathy progression, but the physiologic mechanism is not clear. 
1.3. THE CHOROID — A COMPLEX VASCULAR STRUCTURE. THE DIABETIC 
CHOROIDOPATHY 
1.3.1. ANATOMY AND FUNCTION56–68 
The choroid is a part of the uveal tract of the eye. It is an extensive vascular network 
involved by connective tissue that goes from the ora serrata up to the optic nerve 
and lies between the sclera and the retina. From histology data the choroid varies in 
thickness from 220µ posteriorly to 100µ anteriorly. 
The choroid is supplied by ciliary arteries derived from the first branch of the internal 
carotid artery that pierce the sclera more anteriorly by the long posterior ciliary 
arteries and peripapillary by the short posterior ciliary arteries, until the 
choriocapillaris. The venous drainage is made primarily by the vortex vein system 
that ultimately drain to the superior and inferior ophthalmic veins. 
The enervation of the choroid has parasympathetic and sympathetic nerves, but only 
the latter has an autoregulatory influence in the choroidal blood flow.  
The choroid has a very specific anatomic architecture. Histologically it is divided in 
four layers: the Bruch’s membrane, the choriocapillaris, the stroma and the 
suprachoroid. 
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The Bruch’s membrane separates the retinal pigmented epithelium (RPE) from the 
choriocapillaris. It is essentially a collagenous and elastic fiber tissue. 
The choriocapillaris, described for the first time in the 18th century by Hovius, 
corresponds to the choroidal layer with the smallest vessels, with a 10 to 30 µm 
thickness. It is composed of modified capillaries with an unusual larger diameter (up 
to 40µm) comparing with capillaries elsewhere in the body, and with the particularity 
of fenestrated walls. We can find gap junctions between endothelial cells but there 
are far fewer pericytes as those we find over retinal vascular endothelial cells. The 
support for the vascular system is mostly provided by the involving connective tissue. 
The whole choriocapillaris has an elaborated architecture in various functional 
independent lobules. Each lobule is supplied in its center by a precapillary arteriole 
to the flat and one-layer capillary network that drains into postcapillary venules. 
These characteristics have influence on the high speed of blood flow leakage from 
the capillaries. The choriocapillaris blood flow was found to have up to more 77% 
higher seed than retinal capillaries.  
The stroma is composed of larger vessels than those found on the choriocapillaris, 
and the vessel diameter increases from the choriocapillaris adjacent side to the more 
posterior or scleral one. Involving the vessels there is connective tissue, 
melanocytes, nerve fibers, fibroblasts and non-vascular smooth muscle, 
macrophages, lymphocytes, plasma and mast cells. It is divided into two vessel 
layers: the medium diameter vessel layer or Sattler’s layer, and the large vessel layer 
or the Haller’s layer. The vessels of the stroma are not fenestrated or organized in 
lobules, they are rather intertwined and, especially in the Haller’s layer, the arteries 
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are similar to those elsewhere with contractile ability due to the presence of internal 
elastic lamina and smooth muscle. They don’t leak as the choriocapillaris. The vessel 
system is supported by the involving tissue and cells, and it was suggested that the 
non-vascular smooth muscle and fibroblasts plays a role in the choroidal thickness 
changes occurring in physiologic states as on retinal defocus. 
The suprachoroid separates the Haller’s layer from the lamina fusca (pigmented 
layer of the sclera). It is an avascular layer rich in melanocytes, collagen and elastic 
fibers, fibroblasts and nerve fibers and cells. 
It is important to know the anatomy of the choroid in order to better interpret OCT 
images. 
The physiological role of the choroid is highly related to its blood flow. It is 
responsible for the major supply of oxygen and nutrients to the outer retina with 
particular influence on the metabolic processes of the photoreceptors and light 
absorption due to its rich melanocytes content; it has a retinal thermoregulation role; 
it is important in the immunologic response of the eye since it works as a provider of 
mast and inflamatory cells to the eye and a barrier for certain kind of molecules; and 
it is responsible for about 35% of the humor aqueous drainage with a role in the 
ocular pressure control. Since it is a highly vascular structure with elevated blood 
flow speed, it is also susceptible to systemic changes. Beside those functional roles, 
it has been suggested that the changes in choroidal thickness can be correlated with 
refractive states and even with the eye growth process. 
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The high and speedy blood flow of the choroid and particularly of the choriocapillaris 
is necessary to outdo the barriers of the Bruch’s membrane and retinal pigment 
epithelium to provide the increased amount of oxygen required for the extremely 
metabolically active photoreceptors. The large caliber capillaries of the choroid and 
the fact that they are fenestrated allow permeability to large molecules that do not 
pass through the retinal capillaries, such as glucose, proteins and other nutrients. 
This is important not only for the contribution of nutrients and molecules for the outer 
retina, but also for the removal of the waste produced from metabolic processes of 
the outer retina. 
Choroidal and retinal disorders are intimately related due to the high dependence of 
the normal and efficient outer retina function to choroidal blood flow supply. Systemic 
diseases affecting vascular system or spread by blood can affect both the choroid 
and the retina. A malfunction of the choroid will have a strong effect on the outer 
retina and photoreceptor metabolism. Until now it is not clear if the choroid might 
have an autoregulation mechanism, but the choroid may react in response to retinal 
pathology, as a response to an increased or decreased need for nutrition or 
metabolic input of retinal cells, or to the excessive retinal metabolic products to be 
expelled to blood circulation. 
1.3.2. THE DIABETIC CHOROIDOPATHY 
Diabetic retinal disease is much better known than diabetic choroidal disease, a 
great part because of easier visibility by fundoscopic exam and imaging such as 
fluorescein angiography and first OCTs. 
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Searching PubMed, the first paper using the term “Diabetic choroidopathy” was 
published on 1982 by Sarraco et al., where they described vascular anomalies, 
microaneurysms, and obliterated zones similar to the retinal changes 
of diabetic patients.69 The exact pathophysiology of a Diabetic choroidopathy is still 
unknown, but several histologic and imaging studies indicate changes occurring in 
the choroid in diabetic patients. 
Hidayat and Fine70 in 1985 described histologic findings in eyes of subjects who had 
suffered for long standing Diabetes, with capillary dropout and basement membrane 
thickening. In 1988, Fryczkowski et al71 using scanning electron microscopy also 
found a drop-out of the choriocapillaris and they described additional findings such 
as increased tortuosity, dilation, narrowing, hypercellularity, vascular loop, 
microaneurysm formation, and sinus-like structure formation between choroidal 
lobules. Another important histologic study demonstrating evidence of changes in 
the choroid of Diabetic patients was performed by Cao et al72 in 1998: they described 
two types of choriocapillaris degeneration, focal and diffuse, and the evidence of 
neovascularization and increased basal laminar deposits. Focal choriocapillaris 
degeneration was found to be more prominent in the posterior pole than in the 
equatorial or peripheral choroid, not associated to neovascularization and 4-fold 
greater in diabetics than in nondiabetics. As choriocapillaris degeneration increased 
from focal to diffuse, neovascularization was identified beneath the RPE cells, and 
most were in the peripheral choroid. Diffuse choriocapillaris degeneration was 
associated with increased thickness of Basal Laminar Deposits, suggesting that 
deposition of this material at Bruch’s membrane was related to the atrophy of the 
choriocapillaris. They also postulate that visual acuity loss can occur due to diabetic 
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choroidopathy before having retinopathy. In 2013, Lutty et all73 described same 
findings described previously by Cao et al, but they introduced two types of choroidal 
neovascularization: the intrachoroidal regarding capillary network near the lamina 
fusca, and the extrachoroidal located primarily between the retinal pigment 
epithelium and the Bruch’s membrane and within the latter. Neovascularization was 
found more peripherally. 
Flow studies, whether quantitative or dynamic, also showed evidence of changes in 
the choroid of diabetic patients suggesting Diabetic Choroidopathy. Dimitrova et al 
in 200174 using Color doppler imaging showed that in early stages of diabetic 
retinopathy  the choroidal circulation is affected with findings suggesting occlusive 
or hyper viscosity phenomena reducing blood flow. In 2004, Nagaoka et al75 using 
laser doppler flowmetry demonstrated that the choroidal blood flow in the foveal 
region was significantly lower in patients with Diabetes, especially those with 
macular edema. Pemp et al76, in a review of literature found some contradictory data 
but the most consistent was that studies assessing the choroidal blood flow beneath 
the fovea with the use of laser doppler flowmetry delivered more consistent results, 
indicating a reduction of choroidal blood flow in patients with nonproliferative and 
proliferative diabetic retinopathy. 
Studies using imaging techniques for choroidal and retinal blood flow also 
demonstrated changes in diabetic eyes. Shiragami et al77, found on Indocyanine 
green angiography choroidal abnormalities that they described as: hypofluorescent 
spots, small and large hyperfluorescent spots. The severity of diabetic retinopathy 
was significantly associated with the presence of hypofluorescent spots. Hua et al in 
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201378 also described the same findings and found late choroidal nonperfusion 
regions more predominant in advances stages of retinopathy (proliferative).They 
described an “inverted inflow phenomena” referring to a finding where choroidal 
vessel filling time was longer than retinal vessel filling time. 
Both from histologic and angiographic studies we do have evidence that there is a 
Diabetic choroidopathy. Histologic proof or diagnosis can only be obtained from 
enucleated or post-mortem eyes, with only retrospective value. Angiographic exams 
can be performed in vivo with diagnostic and prospective clinical value, but are 
invasive, and with limited capacity of choroidal changes information due to limited 
resolution and natural image overshadowing by the pigment of the RPE. 
Ultrasonography and Doppler flowmetry are another ophthalmological exams that 
can give limited information when we want to evaluate the choroid. 
The technology improvement in Optical Coherence Tomography in the last 10 years 
has brought about the possibility to evaluate the choroid in a noninvasive exam, 
giving more detailed and new information correlated to physiologic and pathologic 
states. 
1.4. OPTICAL COHERENCE TOMOGRAPHY — A METHOD TO VIEW THE 
CHOROID 
Almost 30 years ago, ocular and especially posterior pole imaging was 
revolutionized with a new technology, the Optical Coherence Tomography (OCT) 
described by Huang et al. from their work at the James Fujimoto laboratory at the 
Massachusetts Institute of Technology (MIT).14,15 The technique was an optical 
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imaging modality using the same rationale of ultrasonography of measuring 
backscattering signal, but using light instead of sound. It allowed in a noninvasive, 
noncontact, simple and rapid way to image cross-sectional anatomy of the retina. 
First in vivo images were shown in 1993 and since 1996 when the first commercial 
device was released, it became widely used and now it is an indispensable tool in 
current clinical practice in Ophthalmology.15,79 OCT is based on low-coherence 
interferometry employing near- infrared light to produce cross-sectional two- and 
three-dimensional high resolution images.14,15,80 
The first device was an innovation for retinal clinical practice, but it had some 
limitations in image quality. Those limitations were related to the scanning speed 
(100 A-scans/second) and the technology used, the Time Domain (TD). Structures 
and layers of the retina were identified by software in a false color code to facilitate 
diagnosis, since the resolution was broad. The quality of images was highly 
susceptible to movement and other factors. In the subsequent models the TD-OCTs 
were improved in image quality, resolution and speed of acquisition. It evolved from 
100 A-scan/s with 20µ of axial resolution for the 1st OCT to 400 A-scans/s with 10 µ 
of axial resolution for the last TD-OCT, the SRATUS from Zeiss. With the latest TD-
OCT, image resolution of the retina and details improved, but due to highly 
pigmented retinal pigmented epithelium, signal was unable to penetrate deeper and 
image the choroid. From the first commercial device, it took about OCT imaging 10 
years to make the leap. The technology switched from Time domain to Frequency 
or Fourier Domain (FD). Basically, the image is obtained from backscattered light as 
frequency information acquired with a light source, charge-coupled device (CCD) 
camera, and a spectrometer, the Spectral Domain OCT (SD-OCT) or by sweeping a 
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narrow-bandwidth source through a broad range of frequencies with a photodetector, 
the Swept source OCT (SS-OCT). These new OCTs use light sources from 880nm 
for SD to 1060nm for SS. With these improvements in technology, along with 
improvement and development of software, tracking, averaging, digital image 
corrections, it is now possible to have devices with axial resolution up to 2µ, 
acquisition speed of 100 000 A-scan/s. Image resolution and depth penetration of 
the signal allow good and detailed visualization of the retina and the choroid, three-
dimensional and volumetric information.15 
The interest and studies of the choroid with OCT were driven with the first description 
of the Enhanced Depth Imaging by Spaide17 with the SD-OCT Spectralis from 
Heidelberg Engineering and later with the SS-OCT. With those technologies the 
difficulty in viewing the choroid and its scleral limit due to scattering of light by the 
pigment of the RPE was solved. With both it become possible to visualize the choroid 
until the scleral limit and sometimes beyond that, with good identification of the 
different vascular layers and the suprachoroidal space. Choriocapillaris microscopic 
details still exceeds the resolution capacity of these devices. 
Several ocular diseases were studied and important findings were reported in 
Central Serous Chorioretinopathy, Diabetic Retinopathy, Glaucoma, Tumors, Age 
Related Macular Disease, High Myopia, Inflamatory diseases and some inherited 
retinal diseases.81,82,83 
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Since OCT choroidal morphologic or anatomic findings were and still are not well 
known, most studies tried to correlate with pathology the easiest parameter to 
evaluate, the choroidal thickness. 
Until the end of 2014, year of start of our study, the status regarding imaging the 
choroid with OCT was as described below. 
Mrejen and Spaide84 published in 2013 a very good review regarding Choroidal OCT 
imaging. They found that in most studies the choroidal thickness was measured with 
the anterior limit at the outer edge of the RPE and the posterior limit of the choroid 
was considered as the inner border of the hyperreflective surface posterior to the 
large choroidal vessels, named as scleral/choroidal interface. Several studies 
evaluated and found good intersystem and interobserver reproducibility and 
repeatability of choroidal thickness measurements.85–93 Studies in normal or healthy 
populations were made in order to determine normal thickness values and the effect 
of various parameters (Table 1)18,86,94–104. 
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Table 1 — Most cited studies of Choroidal Thickness in healthy population 
Legend: n — number; SD — standard deviation; SFCT — subfoveal choroidal thickness; µ - micron; OCT 
— optical coherence tomography technology; SD OCT — spectral domain; SS OCT — swept source. 
Blank spaces mean lack of data on publication. 
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Table 1 shows that there is a great variability between the published studies 
regarding the sample size, mean and range of subjects age. But the greater 
variability is in the subfoveal choroidal thickness (SFCT) measurement, with variable 
mean values with great standard deviations (SD) and large range of thickness 
measurements. Not all studies presented all data, missing in some the information 
regarding SD values or the range of measurements. The studies were performed in 
different ethnicity populations, but no evidence at the time indicates that it can be a 
bias factor. Almost all studies reported strong correlation with age, with a decrease 
in thickness with ageing, some indicating the rate of thickness loss per year.18,96,98–
101,103 But Ding et al in their study stratified the subjects by age and found no 
correlation of choroidal thickness with age in the group less than 60 years old. 
Negative correlation was found only with the older population.100 On the other hand, 
Read et al. in their study in a pediatric population found that choroidal thickness is 
thinner in the youngest and get thicker until the teen age.94 In the largest population 
study, the Beijing Study, they found the greater variability and range of choroidal 
thickness measurements, and found significant correlation with a multitude of 
parameters such myopia, axial length, high blood pressure, deep anterior chamber 
depth and others.104 The great variability of choroidal thickness was noted by Kahn 
et al in a comment to the study of Rahman (more than 80% of choroidal thickness 
variation not explained by age) postulating that other causes may be behind this 
variability than age alone.105,86 Choroidal thickness was evaluated in some studies 
with several measurements in different locations or as macular volume or maps 
measurements.89,95,99,101,106–112,113 The common finding in those studies is that in 
healthy subjects the thicker point of the choroid is found centrally and the thicker 
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quadrant is usually the superior and the thinnest the nasal. Correlation of choroidal 
thickness measurements was found with other factors such as diurnal variation, 
blood pressure, water intake, coffee, thicker choroids.83,92,114–119 Some authors tried 
to look to vascular choroidal morphology.120–126 Most of these studies are 
descriptions of software development with no application or reproducibility for use 
with current available devices used in clinics. Nevertheless Zhang et al. concludes 
in their work that it is possible to do segmentation of most of the choroidal 
vasculature with standard SD-OCT.121 The only study that describes and 
characterizes normal findings on OCT images of the choroidal vasculature was the 
one published by Branchini et al.127 After evaluating images of a wide-age range of 
healthy subjects (23 to 89 years) they conclude that normal/healthy vascular 
morphology on OCT images of the choroid includes the following characteristics: 
1 — choroid is thicker in subfoveal zone; 2 — the posterior boundary or choroid-
scleral border has a convex or “bowl” shape and is clearly identifiable; 3 — there is 
no focal thinning ; 4 — the continuum in size of choroidal vessels axially with “even”, 
i.e., that larger vessels lie closer to the choroid-sclera junction and smaller vessels 
closer to the Bruch’s membrane; 5 — and the large vessels are uniformly spaced. 
Suprachoroidal layer was described only by Rahman86 and Yiu124 as the 
hyporreflective layer or space visualized in some patients, posteriorly to the 
hyperreflective limit that lays after the large choroidal vessels. It is more frequent in 
hyperopic eyes and may be a cause of misjudgment of the correct limit for choroidal 
thickness measurement. 
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1.5. LITERATURE REVIEW ON DIABETIC CHOROIDOPATHY ANALYSED WITH 
OCT 
The literature search was done using the PubMed, Web of Science databases 
engines and Google search using selective and advanced search filters with the 
words: diabetic/ Diabetes/ choroid/ choroidopathy/ OCT/ optical coherence 
tomography, to identify all pertinent and peer-reviewed publications until 2014. 
A few cross-sectional studies were published looking for choroidal changes in 
diabetic patients. The majority of authors found a decrease in choroidal thickness in 
diabetic patients but with different patterns. Esmaeelpour et al. found in type 1 and 
type 2 diabetic patients that the CT was thinner in diabetic patients when compared 
with controls, particularly centrally, but with no correlation with retinal thickness. No 
focal CT thinning was found below retinal lesions128,129 Regatieri et al. and Unsal et 
al. found significant CT thinning when compared with controls only in severe cases 
of diabetic retinopathy (DR) as proliferative diabetic retinopathy (PDR) and macular 
edema (ME). Mean values of CT for control and early stages of DR were similar.81,130 
Querques et al. also found decreased CT in diabetic patients, even with no evidence 
of DR. They describe focal thinning of the choroid correlated with suprajacent retinal 
thickening. In contrast Vujosevic et al. and Lee et al, describe CT thinning but only 
in patients with evidence of DR, and no correlation was found with clinically 
significant macular edema (CSME).131,132 Two groups looked specially for the 
correlation with diabetic macular edema (DME). Hua et al. compared findings in 
subjects with DME and submacular detachment (SMD) or DME without SMD. CT 
was thinner in those patients without SMD.78 Gerendas et al. showed a significant 
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decrease in CT in eyes with DME and in the counter-lateral eye with no DME when 
compared with controls, but no correlation was found between CT and retinal 
thickness (RT).133 When looking to younger populations, Sayin et al. found no 
difference in CT between diabetic and control patients.134 Duration of Diabetes was 
found to have a week correlation with CT by Yülek et al.135 and microalbuminuria 
was found correlated with CT thinning in pre-retinopathy diabetic patients.136 CT 
appeared to increase after intensive control of several systemic and metabolic 
factors.137 There was two studies within all those published until 2014, with a large 
sample of subjects analyzed reporting, controversially, an increase in CT. Kim el al 
found an increase of CT with increasing severity of the DR. Only subjects with treated 
PDR had a decrease in CT. They found that CT increased progressively from cystoid 
DME, diffuse DME to DME with SMD.138 In the other study, Xu et al. found, after 
adjusting for other factors, a significant positive correlation between CT and the 
diagnosis of Diabetes and glycosylated hemoglobin serum values, but none with the 
presence or severity of retinopathy. Significative correlation was found with a variety 
of parameters, ocular and systemic, suggesting that CT measurements are 
multifactorial dependent.139 
Findings had some discrepancies between studies, probably due to different designs 
and analysis made. The sample of subjects also was very variable between studies 
and in several just a few parameters were taken in account (Table 
2)78,128,130,131,136,138–142. 
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Table 2 — Most cited studies of Choroidal Thickness in Diabetic population 
Legend: n — number; SD — standard deviation; SFCT — subfoveal choroidal thickness; µ - micron; NDR 
— no diabetic retinopathy; MNDR — mild/moderate nonproliferative diabetic retinopathy; SNPDR — 
severe nonproliferative diabetic retinopathy; PDR - proliferative diabetic retinopathy; DME — diabetic 
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All authors considered mean thickness values to perform the analysis and 
correlations except on the paper published by Adhi et al.143 On their work they looked 
for choroidal vascular changes occurring in diabetic patients. They used the 
choroidal morphologic features described by Branchini for healthy subjects.127 They 
found that more than 90% of the diabetic patients had irregular choroidoscleral 
contour (or S shaped) in contrast to none on the control group. Diabetic patients had 
thinning of central CT and focal CT thinning zones, more frequent in DME. None was 
found in controls. There was a decrease in large choroidal vessel layer thickness in 
DR eyes. 
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CHAPTER 2 — REASON AND PURPOSE OF THE STUDY 
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2 — REASON AND PURPOSE OF THE STUDY  
From histological, flowmetry and angiographic studies, we do know that there is a 
diabetic choroidopathy. Choriocapillaris drop-out, focal or lobular lesion, occlusion 
and blood flow impairment, vasodilatation, tortuosity and neovascularization are 
changes occurring in the choroid in Diabetes. We also know that the choroid has an 
important role in posterior retinal segment function and choroidal malfunction or 
pathology can be on the origin and/or consequence of the retinal pathology.69,70,144–
146 
Optical coherence tomography has revolutionized imaging of the eye. With the 
improvement of the technology it is now possible with the commercially available 
devices to better view the choroid to study ocular pathology. Several studies were 
published regarding choroid imaging in healthy and diabetic patients. Nevertheless, 
discrepancies in results are found. 
We found a lack of studies trying to correlate vascular morphology of the choroid 
with the retinal disease. The choroid is a tissue with a particular anatomy where 
previous studies had demonstrated a certain independence in function of the lobular 
units of the choriocapillaris and a possible focal effect in the retina immediately 
above. On the other hand, the choroid as a highly vascularized tissue me be affected 
by several other factors, in physiological or pathological systemic conditions. 
Choroidal thickness is a parameter that increases or decreases with choroidal 
vascular changes. But from the studies on healthy populations we can find that there 
is a great variability of measurements, dependent on individual characteristics, age, 
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ocular and systemic factors, and others so a cut off or mean normal value stays 
difficult to establish. Beside the limitations of the published studies pointed above, 
the most important is may be the lack of correlation of morphological findings with 
thickness measurements and longitudinal or over time evaluations for progression. 
2.1. MAIN STUDY PURPOSE 
The main purpose of this study is: 
– To evaluate whether choroidal thickness measurement alone is a reliable 
parameter to characterize diabetic choroidopathy; 
– To characterize choroidal morphological findings using the OCT and correlate 
these findings with choroidal thickness and the diabetic retinopathy 
– To determine if diabetic choroidopathy can be identified, classified and used as 
a biomarker of ocular diabetic disease and progression. 
2.2. SECONDARY, ANCILLARY OR PILOT STUDY PURPOSE 
This study has the following secondary, ancillary or pilot purposes: 
– To explore subjects, diabetic and healthy controls, for ophthalmological facts, as 
best corrected visual acuity, intraocular pressure, biomicroscopy of the anterior 
segment, ocular fundus examination and imaging. 
– To define vascular morphological changes identifiable on OCT images as 
possible markers of choroidopathy 
– To investigate demographics, systemic and metabolic status. 
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– To collect data for both individual and global statistical analysis 
– To provide biomedical translation of our results 
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3 — MATERIAL AND METHODS 
3.1. DESIGN OF THE STUDY AND SETTING  
The whole study consisted in: 
— A PILOT STUDY — A pilot study was performed with a small sample of patients 
that were analyzed for OCT images to define the morphological findings 
classification to be used in the whole and main study. 
— An ANCILLARY STUDY — This study consisted of collecting a small sample of 
images obtained with the swept-source OCT in collaboration with another 
Ophthalmology Department (Instituto Gama Pinto, Lisboa, Portugal) in order to have 
representative images of superimposed retinal e choroidal maps obtained 
automatically by the OCT software. 
— The MAIN STUDY — This consisted in the major data source for the analysis and 
results. The study was performed at the Ophthalmology Department of the Centro 
Hospitalar Entre o Douro e o Vouga (CHEDV), Santa Maria da Feira, Portugal, from 
May 2014 to 2018. It was a cohort, prospective, longitudinal and observational study, 
where diabetic and healthy controls subjects attending the Medical Retina and 
General Ophthalmology consultations were submitted to: complete ophthalmological 
exam; fundus imaging by photography, OCT and Fluorescein Angiography (the later 
when indicated); familiar/hereditary, systemic and metabolic review; blood pressure 
registration; and blood collection when required. The subjects were followed up in 
consecutive visits according to the guidelines for the clinical disease state and 
CHOROIDAL THICKNESS AND MORPHOLOGY ANALYSED BY OPTICAL COHERENCE TOMOGRAPHY AS A 




directed to correct treatment whenever it was indicated. The follow up and evaluation 
period for the study was intended to be for 2 years. 
3.2. MAIN STUDY SUBJECTS 
The subjects participating on the study were divided in two groups: Group 1 of 
Diabetic patients and Group 2 of healthy control subjects. 
3.2.1. GROUP 1 — INCLUSION CRITERIA 
Subjects for this group were selected from the patients attending the Ophthalmology 
department visits, with the diagnosis of Diabetes, with none or any stage of diabetic 
retinopathy, aged 18 or more and who had given and signed voluntarily the consent 
to participate in this study. 
3.2.2. GROUP 2 — INCLUSION CRITERIA 
Subjects for this group were selected from non-diabetic patients attending the 
Ophthalmology department visits, aged 18 or more and who had given and signed 
voluntarily the consent to participate in the study. 
3.2.3. EXCLUSION CRITERIA (BOTH GROUPS) 
Subjects were excluded from the study when one of the following was present: 
unwillingness or inability to give the consent to participate in the study; previous 
treatment of any kind for diabetic retinopathy (laser, intravitreal injection of anti-
VEGF or steroid, vitrectomy); previous or ongoing chorio-retinal disease; history of 
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intra-ocular inflamatory, infectious or oncologic disease; history of ocular surgery; 
media opacities affecting good visualization of the posterior segment; refractive 
errors greater than ± 6 Diopters; systemic oncologic disease; systemic chronic 
steroid or immunosuppressive medication; any serious and uncontrolled systemic 
condition. 
3.2.4. DROP OUT or LOST TO FOLLOW UP (DO or LFU) 
After subject inclusion in the study, if any of the exclusion criteria occurred the 
patient/subject was dropped out from the study. Patients submitted to anti-VEGF 
treatment during the study were dropped out for the natural course and subfoveal 
choroidal thickness progression analysis but were considered for the choroidal 
morphologic changes analysis. If the patient failed to attend any visit other than 
baseline during the study period for any reason, he/she was considered as loss to 
follow up. 
3.3. MAIN STUDY CLINICAL EVALUATION 
All clinical and exams data were collected and registered in the source document 
(the hospital file) and recorded for the study in the Case report forms (CRF). 
The subjects were submitted to clinical history collection for ophthalmological, 
systemic and familiar anamnesis. All were submitted to complete ophthalmological 
exam including: Best corrected visual acuity using ETDRS equivalent charts; 
external ocular evaluation; complete slit-lamp biomicroscopic exam; Goldman 
tonometry; gonioscopy when indicated; dilated fundus exam with auxiliary fundus 
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lenses for posterior pole and periphery observation. Systemic evaluation consisted 
in registration of current medication, recent (within 3 month) blood analysis results 
including glycosylated hemoglobin for diabetics, performed by the family or assistant 
doctor. When not available, these exams were requested. Measurement of blood 
pressure and record of the time of measurement was performed. 
Diabetic retinopathy stage was graded and recorded based on fundoscopy and 
fundus photography observation according to the International Clinical Disease 
Severity Scale for Diabetic Retinopathy38, as follows: No apparent diabetic 
retinopathy (NDR) — no findings found; Mild non-proliferative diabetic retinopathy 
(Mild NPDR) — only microaneurysms (Ma); Moderate non-proliferative diabetic 
retinopathy ( Moderate NPDR) — more than just Ma and less than severe NPDR; 
Severe non-proliferative diabetic retinopathy (Severe NPDR) — more than 20 
intraretinal hemorrhages in the 4 quadrants and/ or venous beading in 2 or more 
quadrants and/or prominent intraretinal microvascular abnormalities (IRMA) in 1 or 
more quadrant with no signs of proliferative DR; Proliferative diabetic retinopathy 
(PDR) — neovascularization of the disc or elsewhere and/or vitreous/preretinal 
hemorrhage. Macular edema classification was based on OCT findings. 
These evaluations were performed in all subject visits. 
3.4. IMAGING ACQUISITION AND ANALYSIS 
Imaging exams consisted of Fundus photography, Optical Coherence Tomography 
and Fluorescein Angiography. All exams were performed by experienced Imaging 
Technician/Orthoptist. 
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3.4.1 FUNDUS PHOTOGRAPHY 
In all visits the subjects of the study were submitted to dilated posterior pole 
photography performed with the Non-midriatic Retinograph TRC NW8® from Topcon 
Corporation. When Fluorescein Angiography was done, fundus photography was 
performed using the Angiograph (see below). 
3.4.2. FLUORESCEIN ANGIOGRAPHY 
Whenever it was clinically indicated, fluorescein angiography was performed 
according to normal procedures for the exam147, using the Digital Angiograph FF 450 
plus® from Carl Zeiss Meditec. Image analysis and report was done always by an 
Experienced Retina Specialist. 
3.4.3. OPTICAL COHERENCE TOMOGRAPHY (OCT) 
3.4.3.1. OCT DEVICES 
Most of the main study’s OCT image acquisitions were performed using the OCT 
CIRRUS HD-OCT® 4000 from Carl Zeiss Meditec. It is a spectral domain OCT using 
a super luminescent diode (SLD) at 840nm, with a scan speed of 27000 A-scans/s, 
an A-scan depth of 20 µ, an axial resolution of 5 µ and transverse resolution of 15 µ. 
The device had un upgraded software with EDI and Fast-track.  
Pilot study’s OCT image acquisitions were performed using the: 
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– OCT RS-3000 Advance® from NIDEK Corporation, Ltd. It is a spectral-domain 
OCT using a SLD at 880 nm, with a scan speed of 53 000 A-scans/s, with 
enhanced retinal and choroidal acquisition protocols and a tracking software. 
– Spectralis OCT2 ® from Heidelberg Engineering. It is a spectral-domain OCT 
using a SLD at 870 nm, with a scan speed of 85 000 A-scans/s, with eye-tracking 
software, increased depth resolution and automated retinal layer segmentation. 
– DRI OCT-1 Triton plus® from Topcon corporation. It is a swept-source OCT 
using a light source of 1050 nm, with a scan speed of 100 000A-scans/s. Its 
software has the particularity to have an automated layer segmentation function 
including the choroid with the ability to provide topographic maps. 
3.4.3.2. ACQUISITION PROTOCOLS 
OCT image acquisition was made for all study subjects in all visits. 
Image acquisition protocols were defined to have 3 dimensional or cube/volume 
information for retinal thickness maps and macular edema location, and line scans 
with best resolution for retina and choroid morphologic evaluation and depth 
penetration for good sclero-choroidal interface identification. 
For the CIRRUS OCT, we performed to all patients the Macular CUBE 512x128 
acquisition protocol centered in the central fovea to obtain the macular thickness 
map. Then a HD line scan with EDI and the maximum averaging of 20 was obtained 
passing through the fovea and in the presence of extra-foveal macular edema 
through the maximum retinal thickness zone. The best line scan for posterior choroid 
limit was selected for analysis. 
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For the RS-3000 OCT we used the Macular CUBE 512x128 acquisition protocol 
centered in the central fovea to obtain the macular thickness map. Then a Macula 
cross scan in the choroidal mode with an averaging of 30 was obtained passing 
through the fovea and, in the presence of extra-foveal macular edema, a line scan 
was obtained passing through the maximum retinal thickness zone. The best line 
scan for posterior choroid limit was selected for analysis. 
For the Spectralis OCT we performed also a macular cube and a line scan with an 
averaging of 20 to 30 following the same guidelines for the other devices. 
The DRI OCT-1 Triton image acquisitions were performed in another Ophthalmology 
department from the Instituto Gama Pinto, Lisboa, Portugal, included in a sub-study. 
Acquisitions were performed to obtain macular thickness maps, line scans with 
choroidal definition in the foveal and macular edema zones, and automated 
choroidal thickness maps. 
3.4.3.3. IMAGE ANALYSIS 
Retinal and choroidal image analyses were made by one of two graders (Lilianne 
Duarte and Miguel Ruão). 
Retinal analysis was carried out to evaluate findings correlated with diabetic 
retinopathy and to identify and locate macular edema. Morphological findings were 
changes in the normal anatomy of the retinal layers (hyper/hyporreflectivity, atrophy, 
cysts, disorganization of retinal inner layers (DRIL), photoreceptors layer integrity, 
new-vessels, subretinal fluid and others). Retinal thickness maps were evaluated to 
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identify Macular edema and classify it as central (foveal involvement) or extra-foveal 
(no foveal involvement). Central foveal retinal thickness (CFRT) value was 
registered. Any other abnormality found was also registered. 
Choroidal analysis was made separately for thickness measurements and 
morphological evaluation. Only sub-foveal choroidal thickness (SFCT) measurement 
was recorded. The measurement was made manually, and boundaries were defined 
as going from the posterior limit of the RPE-Bruch Membrane complex to the outer 
limit of the great choroidal vessels before the hyperreflective layer (figure 1). The 
measurement was made always by the same grader for each eye. SFCT 
measurements were used for the statistical analysis. Images with low resolution or 
quality, hindering the identification of morphological features of choroidal posterior 
boundaries were excluded from the study (figure 2). 
 
 
Figure 1 — Example of boundaries for the measurement of SFCT. 
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Figure 2 — Example of an image with inability to visualize the sclero-choroidal limit. 
 
All OCT scans were made using the device tracking software and follow up images 
were obtained at the same location marked as baseline reference. 
Choroidal morphological analysis was made based on the findings described by 
Branchini et al148 for normal choroid: 1- choroid is thicker in subfoveal zone; 2- the 
posterior boundary or choroid-scleral border has a convex or “bowl” shape and is 
clearly identifiable; 3- there is no focal thinning ; 4- the continuum in size of choroidal 
vessels axially with “even”, i.e., that larger vessels lie closer to the choroid-sclera 
junction and smaller vessels closer to the Bruch’s membrane; 5- and the large 
vessels are uniformly spaced (Figure 3). Additionally, we performed a pilot study to 
characterize abnormal findings in diabetics and establish a classification to use in 
this study. Morphological findings were analyzed and correlated with superjacent 
retina to evaluate any existing anatomical correlation. 
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Figure 3 — Choroidal morphological analysis from Branchini et al. 
From “Analysis of Choroidal Morphology and Vasculature in Healthy Eyes Using Spectral-Domain Optical 
Coherence Tomography”. Ophthalmology, 2013148. Reproduced with permission. A — SD-OCT image of 
a healthy subject with the bowl shape of the sclero-choroidal limit (white line), even distribution of large 
choroidal vessels in the nasal-temporal plane, even continuum of choroidal vessels size with larger 
vessels located outest in the choroid and smaller in the inner choroid. B — SD-OCT image of a diseased 
eye with an irregular “S” shaped sclero-choroidal border (white line), a focal thinning of the choroid (white 
arrow), dislocation of the sub-foveal thickest choroid point and proximity of large choroidal vessels of the 
EPR/Bruch’s membrane posterior border. 
Choroidal automated thickness maps (from SS-OCT images) were compared and 
correlated to superimposed retinal thickness maps and morphologic retina and 
choroid line scans. 
3.5. STATISTICAL ANALYSIS 
Statistical analysis was performed by an external statistician, accessing only the 
coded database and using Stata / SE statistical software version 12.0 (StataCorp 
LLC). 
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The normality of the variables was first tested to select the appropriate statistical 
tests. The normality was tested in general and by groups (control and diabetic) using 
the Shapiro-Wilk test. Since most of the distribution of variables were not normally 
distributed, non-parametric tests were selected 
For continuous variables, the Mann-Whitney test was used to compare two 
independent groups (such as control and diabetic groups). For the comparison 
between more independent groups, such as DR grade, the Kruskal-Wallis test was 
used. For categorical variables the Fisher's test was used. The differences between 
two dependent variables (e.g. between visits), as well as between OD and OS, were 
performed using the Wilcoxon test for continuous variables. For categorical variables 
the McNemar test (for 2x2 tables, e.g., ME) or Stuart-Maxwell (for tables with more 
categories, e.g. DR grade) were used. Correlations between variables were obtained 
with the Spearman correlation coefficient. 
In order to identify predictive variables for one continuous variable, and to study the 
impact these independent variables on a dependent variable (e.g. SFCT), a 
multivariate linear regression model was performed. 
Statistical significance was considered for p-values lower or equal to 0.050. 
3.6. ETHICS AND CONFIDENCIALITY COMPLAINCE 
The protocol of the study with the internal number CHEDV-OFT-01-14 and patient 
informed consent form was submitted to the Ethics Committee and Administration 
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Board of the CHEDV and approval was given on May 15th, 2014 (copy of the 
documents in Appendix 2 and 3). 
The study was conducted following the tenets of the Declaration of Helsinki. 
Data confidentiality was assured by coding patient identification on the database for 
analysis. 
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4 — RESULTS 
4.1. PILOT STUDIES 
A pilot study was performed to identify markers or morphological findings to 
differentiate normal from abnormal choroid and create a classification system for the 
study. The evaluation was first based on the classification made by Branchini et al148 
and then modified according to our findings. The results of this pilot study were 
presented at two congresses: 
1. At the 15th EURETINA Congress, in September 2015, the results of this pilot study 
were presented with the poster entitled, “Looking beyond thickness: choroidal 
findings with the Nidek OCT RS-3000 Advance”. 
Thirty eyes of thirty patients were included; 12 of which were from healthy controls 
and 18 from diabetic patients. In the diabetic group, 7 eyes had no DR, 5 eyes had 
mild NPDR and 6 eyes had ME and/or PDR. 
OCT images were evaluated for choroidal morphological changes choroidal findings 
were classified as: 
— Normal (figure 4) — when the sclero-choroidal border had an “inverted dome 
shape” (the bowl shape from Branchini) with the thickest choroidal point sub-foveal, 
and the “mottled” vascular layer of the choroid (corresponding to the choriocapillaris 
and Sattler’s smaller vessels layers) had an imaginary line limit to the great vessels 
layer that lays parallel to the Bruch’s membrane and/or the sclero-choroidal limit. 
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Figure 4 — Normal choroid morphology classification — pilot study. 
Upper image showing the normal fundus and the choroid vascular feature. On the bottom the same image 
with the delineation limits: the Bruch’s/RPE posterior border (purple line), the imaginary parallel line 
separating the mottled choriocapillaris/Sattler’s layer and the great vessels layer (turquoise line) and the 
sclero-choroidal border (blue line). 
— Abnormal (figures 5-7) — when one or more of the following changes were found:  
a loss of the “inverted dome shape” of the sclero-choroidal border; the vascular 
layers with absence or atrophy of great vessels layer; the choriocapillaris/Sattler’s 
layer with focal or diffuse atrophy; irregularity of the parallel layers delineating line; 
and hyperreflective focal zones instead of the vascular hyporreflective images. 
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Figure 5 — Abnormal choroid morphology in Diabetic Macular Edema — pilot study. 
Upper image showing the fundus image with CSME and the choroid vascular feature. On the bottom the 
same image with the delineation limits: the Bruch’s/RPE posterior border (purple line), the imaginary line 
separating the mottled choriocapillaris/Sattler’s layer and the great vessels layer (turquoise line) 
irregular/non- parallel due to focal zones with atrophy or thinning (yellow arrows), focal lack of great 
vessels with hyperreflective space (green arrows), and the sclero-choroidal border (blue line) slightly 
irregular. 
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Figure 6 — Abnormal choroid morphology in PDR — pilot study. 
On the fundus image large new vessels of the disc (NVD) and elsewhere (NVE) on the superior temporal 
arcade are seen. On the OCT line image: the Bruch’s/RPE posterior border (purple line), an apparent 
preserved mottled choriocapillaris/Sattler’s layer, the great vessels layer with a focal zone with atrophy 
and hyperreflective space temporally, and the sclero-choroidal border (blue line) slightly irregular with 
apparent moderate thinning of choroidal thickness. 
 
Figure 7 — Abnormal choroid morphology in PDR — pilot study. 
This patient had new vessels on the retinal periphery. On the OCT line image: the Bruch’s/RPE posterior 
border (purple line), but a very thin/atrophic choroid with atrophy of all layers and the inability to draw a 
limit between them. Loss of the “inverted dome shape” of the sclero-choroidal border (blue line). 
When choroidal morphological changes were analyzed for the different groups, we 
found that, with the advance of the disease, there was a progressive loss of the 
normal “inverted dome shape” of the sclero-choroidal border and, with macular 
edema, focal changes in the vascular layers were noticed suggesting a 
vascular/blood recruitment of focal retinal suffering zones (figure 8). 
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Figure 8 — Progressive change in choroid morphology in the different DR stages. 
Legend: 1 — Healthy control. 2 — Diabetic with no DR. 3 — NPDR. 4 — PDR. 5 — CSME. 
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2. At the EVER Congress on October 2015 the results of the pilot study were 
presented with the poster “Focal Choroidal Changes on Diabetic Macular 
Edema” (published abstract on the Acta Ophthalmologica149). 
Fifty-four eyes were included in this study: 8 with macular edema, 12 with non-
proliferative diabetic retinopathy, 22 with no retinopathy and 12 controls. Age ranged 
from 22 to 80. Choroidal thickness varied from 61µm to 495µm. No correlation was 
found between SCFT and age, blood pressure or diabetic stage. Choroidal thickness 
showed high standard deviations values (Table 3). 




TOTAL 44 56.56±13.45 301.65±88.56 138.18±18.57 71.02±8.11     
CONTROL 12 50.58±12.59 312.08±41.85 132.17±20.14 74.75±19.52     
NDR 22 53.5±12.59 341.64±87.34 136.95±18.07 77.99±12.53 9.96±6.64 7.18±1.12 
NPDR 12 62.67±9.71 265.42±75.79 137.33±18.44 75.33±8.56 13.42±5.55 7.76±2.05 
ME/PDR 8 64.75±12.01 230.38±107.00 150.63±14.68 74±8.8 14.75±5.42 9.23±1.45 
Table 3 — Demographics and Mean values of SFCT — pilot study 
Legend: n — number; SFCT — subfoveal choroidal thickness; SBP — systolic blood pressure; DBP — 
diastolic blood pressure; HA1c — glycosylated hemoglobin; NDR — no diabetic retinopathy; NPDR — 
non-proliferative diabetic retinopathy; PDR - proliferative diabetic retinopathy; ME — macular edema. 
In this study we found that, for advanced stages of retinopathy and macular edema, 
the changes in the architecture of the choroidal vessels with a tendency of vanishing 
of the large vessels in favor of the smaller and choriocapillaris and the changes in 
the sclero-choroidal border shape, were well correlated to the superjacent area of 
retinal active disease and edema. 
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4.2. MAIN STUDY 
The patient’s study data collection was from May 2014 to February 2018. 
One hundred and eighty-one patients (362 eyes) were selected for this study, where 
129 (258 eyes) were diabetic patients (13 with type 1 Diabetes and 116 type 2 
Diabetes) and 52 (104 eyes) were controls non-diabetic patients. Eighty-one (88) 
eyes were excluded from the study due to the following: 75 eyes — inability to identify 
the posterior limit of the choroid on the OCT image; 6 eyes — previous cataract 
surgery; 2 eyes — epiretinal membrane with traction; 2 eyes — previous focal 
macular laser; 1 eye — foveal atrophy from other causes; 2 eyes — drusen and 
foveal vitelliform lesion. 
From the 274 eyes included in the study, 36,1% (99) had a second visit, 8.8% had 3 
visits and only 3.9% had 4 visits during the study period. The eyes needing any kind 
of treatment considered as exclusion criteria were directed to do the treatment and 
were considered as drop-out of the study. Subjects with eyes with no disease or no 
need for treatment were counseled to perform a regular visit (6 months or 1 year 
later). Since it is an observational study, the scheduling of the visits was dependent 
on the family doctor and/or patient. Therefore, 36 eyes were dropped-out from the 
study: 4 had to be submitted to cataract surgery, 14 were directed to a loading dose 
of intravitreal anti-VEGF, 16 were directed to perform macular laser treatment and 2 
eyes due to ocular hyperpressure, started medication with Latanoprost drops. 80 
patients (160 eyes) did not have any other visit during the study period for unknown 
reasons, so they were considered as loss to follow up (LFU). Due to the small sample 
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of eyes with more than 2 visits, data were not considered for statistical analysis. The 
interval of time between the baseline visit and the second visit was of mean ± SD: 
424 days ± 238 (mean 14 months: minimum 61 days maximum 1012 days) for 
diabetic patients and mean ± SD: 391 ± 276 (mean 13 months: minimum 105 days 
maximum 854 days) for healthy controls. 
 
The analysis was made for morphological changes and for statistical results. 
4.2.1 MORPHOLOGICAL ANALYSIS 
For the morphological analysis all OCT images were observed and classified 
according to the retinal and choroidal macular anatomical/ morphological features. 
 
Assessed for eligibility (n=181 
patients/ 362 eyes) 
 (  ) 
Excluded  (n=88 eyes) 
   Not meeting inclusion criteria 
Lost to follow-up/Discontinued (n=111) 
Eyes in study (n= 85) 
Group 1 Diabetics (n= 196 eyes ) 
Lost to follow-up/Discontinued intervention (n= 64) 
Eyes in study (n=14) 
Group 2 Healthy Controls (n= 78 eyes ) 
Baseline 
Follow-Up Visit 2 
Randomized (n=274 eyes ) 
Enrollment 
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Retinal analysis consisted in evaluating and classifying images as normal (with no 
abnormalities) or abnormal with diabetic retinopathy findings. The DR findings could 
be: evidence of increased thickness (focal or diffuse) in the retinal thickness map, 
cysts, hyperreflective spots (hemorrhages/exudates), disorganization of the layers, 
atrophy, fibrosis, new vessels, fibro-vascular proliferation, or others. 
Choroidal analysis was based on the classification from the findings of the pilot 
studies as follows: normal sclero-choroidal border — with the “inverted dome shape” 
and the thickest point below the fovea; normal layers — with integrity of the mottled 
choriocapillaris/Sattler’s (ChS) and parallel to the Bruch’s membrane, homogeneity 
of the great vessels distribution; abnormal sclero-choroidal border — with loss of the 
“inverted dome shape” and irregular delineation; abnormal layers — with loss of the 
integrity of the mottled choriocapillaris/Sattler’s and parallel to the Bruch’s 
membrane, focal atrophy or increase thickness of vascular layers, loss of even 
distribution, hyperreflective spaces on the vascular zone. 
The choroidal findings were correlated with the retina above. 
For the 196 diabetic and 78 healthy eyes included at baseline the choroidal 
morphologic features are summarized by groups as shown in table 4. 
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Healthy eyes n (%) Diabetic eyes n (%) 
N-N    SCI — CL 61 (78.2) 106 (54.1) 
N-AN    SCI - CL 8 (10.3) 34 (17.3) 
AN-N    SCI - CL 2 (2.6) 8 (4.1) 
AN-AN    SCI - CL 4 (5.1) 48 (24.5) 
AN- Imp    SCI - CL 1 (1.3) - 
N- Imp    SCI - CL 2 (2.6) - 
Total eyes (n) 78 196 
Table 4 — Main study - choroidal morphologic features by group. 
Legend: N — normal; AN — abnormal; SCI — sclero-choroid interface; CL — choroidal layers; Imp — 
impossible to evaluate. 
About 78% of the healthy ones had all choroidal morphological features classified as 
normal.  When analyzed individually the greater cause of some abnormalities was 
due to vascular layer abnormalities (12 eyes — 15.4%) and we observed that it was 
always due to some irregularities in the great vessels layer, being the 
choriocapillaris/Sattler’s layer always preserved. The irregularity of the SCI was a 
consequence of localized thinning of the great vessels layer. The 3 cases where it 
was impossible to classify CL were due to the extreme thinness of the choroid in the 
oldest patients (all 79 years old). Examples are shown in figures 9 to 11 below. 
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Figure 9 — Choroidal morphologic changes in Control. 
Three examples of irregularity of the SCI due to localized atrophy of the great vessels layer (most 
frequently nasally located) or loss of great vessels with hyperreflective zone (temporally on the OCT image 
2). 
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Figure 10 — Choroidal morphologic changes in Control. 
Two examples of normal contour of the SCI with abnormal CL due to localized atrophy of the great vessels 
layer and/or loss of great vessels with hyperreflective zone, but with preservation of the 
choriocapillaris/Sattler’s layer.  
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Figure 11 — Choroidal morphologic changes in Control. 
Example of a very thin choroid where it is impossible to differentiate the layers boundaries. 
In the diabetic group, 54.1% of the eyes had no choroidal morphologic abnormalities. 
Most eyes with choroidal abnormalities had vascular changes (41.8%) compared 
with those with just sclero-choroidal irregularities (4.1%). The sclero-choroidal border 
was always correlated with or due to changes in the normal distribution of the great 
vessels (enlargement, atrophy or loss), except in one case where we found an 
anatomical variation with a triangular shape sub-foveal (figure16). 
SCI-CL NDR MildNPDR ModNPDR Sev/PDR Maculopathy 
N-N (n= 106) 71.7% 19.8% 8.5% 0 18.5% (5) 
N-NA (n= 34) 50% 29.4% 20.6% 0 29.6% (8) 
AN-N (n=8) 75% 25% 0 0 0 
AN-NA (n=48) 56.3% 16.7% 18.7% 8.3% 51.9% (14) 
Table 5 — Correlation of choroidal morphologic findings with the retinopathy grade. 
Legend: SCI — sclero-choroidal interface; CL- choroidal layers; N- normal; AN — abnormal; NDR — no 
diabetic retinopathy; MildNPDR- mild non-proliferative diabetic retinopathy; ModNPDR- moderate non-
proliferative diabetic retinopathy Sev/PDR- severe or proliferative diabetic retinopathy. 
When correlating choroidal morphological findings with the retinopathy grade and 
the presence of maculopathy, we found that most of the diabetic eyes with no 
choroidal abnormalities had no DR or only initial stages of DR (table 5). Five of these 
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had extra-foveal focal macular edema, and only in those focal locations choroidal 
changes were evident (figure 22). Choroidal vascular abnormalities were more 
prominent in the presence of macular edema or diabetic retinopathy. More advanced 
choroidal morphological changes with both SCI and Vascular layers affected were 
associated to more advanced retinal disease. 
From individual OCT image observation, we found that: 
— Changes in the great vessel layers are the major responsible for the irregular 
sclero-choroidal border, usually due to focal atrophy or thinning, loss of vessels with 
hyperreflective spaces occupying the vessels space or hypertrophy. 
— In the absence of evident retinal disease and changes in the 
choriocapillaris/Sattler’s layer, great vessels layer abnormalities are usually caused 
by focal loss or atrophy (more frequently located nasally to the fovea), or loss of even 
distribution. 
— Changes on the choriocapillaris/Sattler’s layer such as focal atrophy/loss with the 
approach of the great vessels to the Bruch’s membrane, hypertrophy associated with 
focal thinning or loss of subjacent great vessels, are correlated with changes in the 
retinal anatomy above. It becomes more evident in the presence of macular edema 
especially if the photoreceptor layer is affected. 
— With maculopathy, we can find focal thinning of the choriocapillaris/Sattler’s layer 
below the affected retina (ex- initial Cystoid macular edema with mild lesion of the 
retinal layers) with prominent choroidal great vessels, or more frequently associated 
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to the presence of hard exudates, disorganization of retinal layers, lesion/atrophy of 
photoreceptors, we can find a focal enlargement of the choriocapillaris/Sattler’s layer 
below the affected retina with thinning or loss of the great vessels layer. 
— Independent of the retinal stage, if there is a severe choroidal thinning, it becomes 
difficult to analyze and classify choroidal morphological changes. 
 
Figure 12 — Choroidal morphologic changes in a Diabetic with no retinopathy. 
An NDR eye with integrity of the choriocapillaris/Sattler’s layer but with a nasal thinning of the great 
vessels leading to a nasal thinning of choroidal thickness and irregular SCI. 
 
Figure 13 — Choroidal morphologic changes in a Mild non-proliferative retinopathy. 
Mild NPDR eye with small retinal lesions foveal and nasal to fovea with subjacent loss of great vessels 
and hypertrophy of the choriocapillaris/Sattler’s layer, and temporally to the fovea some irregularities of 
the retinal outer plexiform layer with subjacent slight thinning of the choriocapillaris/Sattler’s layer with an 
enlargement of the great vessel. 
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Figure 14 — Proliferative diabetic retinopathy with normal choroidal morphology. 
PDR where the most affected retina is in the internal layers with integrity of the outer retina. Note the 
regular choroid with no morphologic changes. 
 
Figure 15 — Choroidal morphologic changes in Macular edema. 
A Macular edema with slight neurosensorial detachment (NSD) and some chronicity signs. Note the lack 
of great vessels below the NSD and nasally below the hyperreflective lesions in the retina a slight atrophy 
of the choriocapillaris and great vessels enlargement. 
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Figure 16 — Variation of normal choroidal vessels morphology. 
The case of the anatomical variation with a triangular shape of the SCI, probably corresponding to a 
posterior ciliary artery choroidal penetration. 
 
Figure 17 — Choroidal morphologic changes in a Mild non-proliferative retinopathy. 
Mild NPDR with temporal macular Microaneurysms and small hemorrhages on fundoscopy, and the OCT 
image showed an irregular SCI with loss of the inverted dome shape due to a temporal thinning related 
to loss/atrophy of temporal great vessels. 
CHOROIDAL THICKNESS AND MORPHOLOGY ANALYSED BY OPTICAL COHERENCE TOMOGRAPHY AS A 





Figure 18 — Choroidal thinning with age. 
Two examples of older patients with very thin choroid where morphological classification is difficult. 
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Figure 19 — Choroidal morphologic changes in Macular edema. 
An exuberant cystoid macular edema with greater cysts centrally, with a small NSD, slight inner retinal 
layers edema, and temporally to the fovea focal zones of atrophy of the photoreceptors layer. Under the 
nasal retina where the outer retina (from the outer nuclear layer to the EPR) has no relevant changes, the 
choroid is thinner with lack of great vessels and hypertrophy of the choriocapillaris/Sattler’s layer. Under 
the NSD there is an enlargement of the great vessels. Under the focal zones temporally with atrophy of 
the photoreceptors there is a focal atrophy of the choriocapillaris/Sattler’s layer immediately below with 
invasion of a great vessel. 
 
Figure 20 — Focal retinal and subjacent choroidal morphologic changes. 
Focal retinal DR changes with corresponding focal thinning of the choroid right below associated with 
loss/atrophy of great vessels. 
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Figure 21 — Focal retinal and subjacent choroidal morphologic changes. 
A temporal macular edema with some exudates and cysts. Below the more fluidic cysts (hyporreflective 
content) no relevant choroidal morphologic features are noted, but below the more chronic/ organized 
retinal lesions (exudates and cysts with lightly hyperreflective content) there is a lack of great vessels and 
thickening of the choriocapillaris/Sattler’s layer. 
 
Figure 22 — Focal retinal and subjacent choroidal morphologic changes. 
An example of focal extra-foveal retinal thickening (spared fovea) where in the same scan we can see the 
choroid below the retinal focal thickening with the lack of great vessels replaced by hyperreflective space, 
comparing to the choroid beside (nasal) with some great vessels visible. 
We looked for progression changes on diabetic eyes. Eighty-five eyes were analyzed 
looking for CT increase or decrease from baseline to the second visit. The CT 
change was correlated with the RT changes and morphological findings. 
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Increase 67.7% 19.4% 12.9% 
Decrease 50% 15.4% 36.6% 
No change 81% 9.5% 9.5% 











Increase 21.4% 43.8% 34.8% 
Decrease 16.9% 21.1% 62% 
No change 33.3% 41.2% 25.5% 
Table 7 — Correlation of retinal thickness changes with choroidal thickness 
progression. 
 
As can be seen in table 6, more than half of the eyes having a change in choroidal 
thickness from baseline to visit 2 had no retinal thickness changes. But one third of 
the eyes with choroidal thickness decrease had also a retinal thickness decrease. 
However, when inverting the analysis (table 7), we found that more than half of the 
eyes with decreased Retinal thickness had also a decrease in CT, while the 
distribution was more equitable when a RT increase, or no change was found. 
Just a few eyes had moderate thickness changes and even fewer had huge 
thickness changes. No pattern stands out from these results. 
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In figures 23 to 33 below, we show some examples of progression of retinal disease 
and/or choroidal disease. 
 
Figure 23 — Example in Macular edema progression. 
Image 1 — baseline visit; image 2 - visit 2 (about 1 year later). There was a mild CT increase (<30 µ) and 
a severe RT increase (+256 µ). Beside the thin choroid that limits the morphologic evaluation we can 
observe on V2 less vessels with larger caliber, particularly under the central zone of the macular edema. 
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Figure 24 — Example of CT increase with no retinal changes. 
From baseline (image 1) to V2 (image 2) there was slight increase in CT with no changes in RT. We can 
observe that there is a slight enlargement in great vessels that can explain the increase in CT. 
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Figure 25 — Choroidal morphologic changes in Retinal improved progression. 
From baseline (left) to V2 (right) there was a moderate increase in CT (+ 42µ) and focal decrease in RT 
(Retinal thickness maps below the line scan images). We can observe on BL two focal zones where there 
is a hypertrophy of the choriocapillaris/Staller’s layer (temporal and nasal of the center) that on the nasal 
one corresponds to some irregularities of retinal layers (Outer plexiform). On V2 there is a recovery with 
great vessels on the temporal focal zone, but not on the nasal zone where persists the retinal irregularities. 
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Figure 26 — Choroidal morphologic changes in Retinal worsening progression. 
From baseline (left) to V2 (right) there was a moderate focal increase in RT (Retinal thickness maps below 
the line scan images). Choroidal changes are subtle, but we can observe on BL temporal to the central 
zone a horizontal great vessel that is replaced on V2 by hypertrophic choriocapillaris/Sattler’s layer and 
hyperreflective space. Under the NSD and exudate zone there is an atrophy of the 
choriocapillaris/Sattler’s layer losing the mottled aspect and being plainer hyperreflective. 
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Figure 27 — Choroidal morphologic changes in Retinal worsening progression. 
On baseline image (left) we can observe the loss of the inverted dome shape of SCI, with scarce great 
vessels with focal loss (nasally and just temporally to the center). One year later, in V2 (right) there was 
a moderate focal increase in RT (Retinal thickness maps below the line scan images) and outer retinal 
layers changes nasally.   These changes are above the choroidal changes observed on BL, which persist 
and are more evident. The CT increase from 243µ to 252µ. 
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Figure 28 — Progression in a Diabetic with no retinopathy. 
A case of an eye with non-visible diabetic retinopathy with 2 years of interval between baseline (left) and 
V2 (right). There was a mild choroidal thinning with focal loss of great vessels temporally, replaced by a 
hypertrophic ChS layer and a hyperreflective space. 
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Figure 29 — Choroidal morphologic changes in a macular edema progression. 
On baseline image (left), of a mild NPDR eye, we can observe the loss of the inverted dome shape of 
SCI, irregular vessels layers with focal zones of loss of great vessels, atrophy or hypertrophy of ChS, but 
with no evident retinal changes. Six months later there was a CME with an increase in CT from 219 to 
248µ with a change in choroidal vessels with more larger vessels near the posterior border of Bruch’s 
membrane. 
 
Figure 30 — Choroidal morphologic changes in retinopathy grade progression. 
An evolution with a 6-months interval between the visits. DR evolved from NDR to mild NPDR and 
moderate NPDR (from left to right). The retinal maps below the OCT line images show the RT progression. 
In the line scans, we can observe on BL focal zones with hypertrophy of the ChS and loss of great vessels, 
and progression of retinal diabetic changes occur above those focal choroidal zones. 
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Figure 31 — Choroidal morphologic changes in a macular edema progression. 
Evolution during one year of an eye with mild to moderate NPDR evolving to ME. CT was from the first to 
the last visit of 344µ ,324µ,326µ and 325µ. The retinal changes are a progression to temporal CME, and 
some irregularities on nasal retinal layers that regress on the latest visits. Choroidal vascular changes are 
a focal increase of the ChS both below nasal and temporal changes zones, but while nasally it remains 
with the regression of retinal changes, temporally with the progression to CME the great vessels enlarge 
and approach to the Bruch’s side. 
We evaluated some eyes that had been dropped out from the natural course study 
because they had been directed to treatment of macular edema. The purpose was 
to observe what changes occur in the choroid after resolution or recovery of the ME. 
Below are the examples.  
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Figure 32 — Choroidal morphologic changes after macular edema resolution. 
An eye that evolved to CME with mild NSD that was resolved with intravitreal anti-VEGF. On V1 there is 
a thin choroid with 3 central great vessels pushing up to the Bruch’s the ChS, corresponding to the zone 
below of where the CME appeared (affected retina). With the progression to V3 the changes that we can 
observe are a moderate decrease in CT (245µ-240µ-189µ) which we can correlate with the decrease in 
great vessels caliper. 
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Figure 33 — Choroidal morphologic changes after macular edema resolution. 
Baseline with ME and two years after ME treatment. There was an almost complete regression of ME 
with residual cysts and irregular layers. The initial choroid with loss of great vessels under the CME, 
recovered some great vessels, but thickness decreased from 289µ to 222µ. Note that there is a slight 
retinal thinning temporally although no layers/morphology changes observed, with a corresponding 
enlargement of a choroidal great vessel pushing ChS to the Bruch’s border.  
4.2.2. ANCILARY MORPHOLOGICAL STUDY 
We evaluated automated retinal and choroidal thickness maps acquired with the 
Swept-source DRI OCT-1 Triton to correlate localized retinal changes with 
superimposed choroidal changes (unpublished data). 
The results are shown in the figures below. 
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Figure 34 — Choroidal thickness maps in healthy and different retinopathy stages. 
1st column — fundus photography. 2nd column — central line OCT scan. 3rd column — retinal thickness 
map. 4th column — choroidal thickness map. A — healthy subject. B to F — diabetic patients in different 
stages. Yellow arrows — abnormalities of the choroidal vessels. Detailed description in the text. 
Six eyes were analyzed using the SS-OCT retinal and choroidal automated 
thickness maps. One healthy and five with different types of diabetic retinopathy. 
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Case A — A healthy 21-year-old (y.o.) man. 
On the line scan we can observe the normal morphology as described previously 
(figure 4) with the “inverted dome shape” sclero-choroidal border, integrity and 
parallelism of the choriocapillaris/Sattler’s layer and uniformity of the great vessels 
layer. The retinal thickness map is normal according to the well-described features, 
with the foveal depression, the slightly thickest circle surrounding the fovea with a 
progressive thinning to the periphery. The choroidal thickness map with thickest 
zone centrally, superiorly, temporally and inferior to the fovea in a continuous or 
uniform distribution. 
Cases B and C — Right and left eye of a 63 y.o. male diabetic subject with mild non-
proliferative diabetic retinopathy. 
On the right eye (B), with microaneurysm only mostly located temporally and 
superiorly in the macula, the retinal thickness map is normal, but the choroidal 
thickness map shows a decreased thickness primarily temporal and inferior 
comparing to the healthy case. On the line scan there is a focal thinning of the 
choroid (yellow arrow) corresponding to a zone with fewer great vessels and minor 
abnormalities of the retina above. On the left eye (C), microaneurysms are 
throughout the macula, with a small exudate temporal in the macula. The line scan 
shows small cysts temporal to the fovea and general decreased thickness of the 
choroid with atrophy of both group of vascular layers. The retinal map evidences 
focal increased thickness superior to the fovea. The choroidal thickness map shows 
a slightly higher decrease in thickness compared with the right eye, but the location 
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with higher thickness corresponds to the retina above with higher thickness.  
Case D — A 51 y.o. diabetic male subject, with moderate diabetic retinopathy. 
Fundus image shows microaneurysms, hemorrhages and little macular exudates. 
The line scan shows some diabetic lesions in the retina with a cystoid macular 
edema involving the fovea with some loss of integrity of the central photoreceptor 
layer, and complete vanishing of the choroidal great vessels below this affected 
photoreceptor zone (yellow arrow). The retinal thickness map shows focal zones with 
increased thickness, but the choroidal thickness map, despite being abnormal as 
compared with the healthy case, does not have a logical thickness distribution 
correlated with the retinal map. It seems that the thinnest zone corresponds to the 
retinal zone with more exudates (temporal). 
Case E — A 67 y.o. diabetic woman, with mild NPDR and a CME. 
The line scan shows a foveal important cyst with almost no apparent lesion of the 
photoreceptors layer, and integrity of the choriocapillaris/Slater’s layer with loss of 
the inverted dome shape and the subfoveal thickest choroidal point. Retinal map 
shows the central edema and the choroidal map a general slight thickness decrease. 
Case F — A 70 y.o. diabetic man, with mild to moderate NPDR with ME non-involving 
the fovea. 
The foveal line scan shows integrity of the fovea and photoreceptors layers with 
small cysts and slight disorganization of the layers temporal to the fovea. The choroid 
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has the normal inverted dome shape, and the choriocapillaris/Slater’s layer is almost 
normal with only a slight increased thickness on the temporal side (below the 
affected retina). The retinal thickness map shows the ME, and the choroidal map 
shows the normal thickest point centrally but with a slight decrease in thickness 
temporally and inferiorly when comparing with the healthy case. 
4.2.3. STATISTICAL RESULTS 
For the analysis, both eyes were included, if eligible by the inclusion criteria, since 
the variables to be studied for the principal purpose were specific for each eye and 
independent of the contralateral eye. Thus, non-ocular variables are presented 
demographically by patient (age, sex, systolic blood pressure, diastolic blood 
pressure, HbA1c, duration of Diabetes) while eye variables are presented by eye 
(best corrected visual acuity, refractive error, ocular pressure, subfoveal choroidal 
thickness, central foveal retinal thickness, choroidoscleral interface contour, 
choroidal vascular layers, stage of diabetic retinopathy). In order to facilitate the 
statistical analysis, choroidal morphologic features were divided in contour (Sclero-
choroidal border delineation) and layers (vascular layers — great vessels and ChS 
layer). Both variables could be normal or abnormal. 
Visual acuity was recorded on a 20/20 ETDRS chart. For analysis, the denominator 
was registered (example: 20/40 VA was recorded as 40). The refractive error was 
recorded as spherical equivalent. 
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Group 1 — Diabetics 
Baseline demographics for generic, systemic and non-retinal or choroidal variables 




Mean Std. Dev. Min Max 
Age 196 57.8 12.8 18 81 
Gender (F/M) 196 88 (44.9%) / 108 (55.1%) 
VA 196 23.0 9.1 20 100 
 RE 196 0.1 2.2 -2.5 3.5 
SBP 165 140.5 20.0 105 197 
DBP 165 76.4 13.6 45 132 
OP 174 15.5 3.3 10 27 
Table 8 — Demographics of Diabetic group (analysis per eye). 
Gender — F- female, M- male; VA — visual acuity; RE — refractive error; SBP — systolic blood 
pressure(mmHg); DBP — diastolic blood pressure(mmHg); OP- ocular pressure (mmHg). 
Table 9 — Demographics of Diabetic group (analysis per subject). 
 
For group 1, diabetic subjects, data regarding SFCT, CFRT, HbA1c and duration of 
Diabetes are summarized on table 10 and SFCT mean values for each diabetic 




Mean Std. Dev. Min Max 
Age 78 57.8 12.8 18 81 
Gender (F/M) n 78 44 / 56  
SBP 74 141.5 20.2 105 197 
DBP 74 76.5 13.5 45 132 
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Variable n Mean (µ) ± SD Min (µ) Max (µ) 
SFCT 196 273.4 80.9 96.0 495.0 
CFRT 196 271.3 45.3 209.0 517.0 
HbA1c 183 7.4 1.8 5.1 13.6 
Diabetes 
(years) 196 12.6 8.3 0.5 40.0 
Table 10 — Diabetic group — Choroidal and retinal thickness and metabolic status. 
Legend: SFCT (subfoveal choroidal thickness), CFRT (central foveal choroidal thickness), HbA1c (serum 
glycosylated hemoglobin) and duration of Diabetes 
DR stage n (eyes) 
Mean 
SFCT (µ) 
± SD Min Max 
NDR 125 264.32 81.08 96 495 
MildNPDR 42 262 65.60 113 391 
ModNPDR 25 265.64 85.46 100 423 
SevNPDR/PDR 4 336.75 55.57 268 404 
Maculopathy 27 262.81 85.10 100 461 
Table 11 — Diabetic group — Choroidal thickness for each Diabetic retinopathy (DR) 
stage. 
Legend: SFCT — subfoveal choroidal thickness; NPDR — nonproliferative diabetic retinopathy; Mod — 
moderate; Sev — severe; PDR — proliferative diabetic retinopathy 
On thirteen patients, the HbA1c failed to be registered for other reasons (e.g., failure 
to do the analysis with the family doctor). Patients were in global relatively well 
controlled for Diabetes and blood pressure. Most eyes had no evident diabetic 
retinopathy or mild NPDR. Only 27 eyes had macular edema (central or focal extra-
foveal). 
SFCT had a huge range of measurements varying from 96 to 495µ as shown in 
graphic 1. When analysing SFCT distribution by age for all eyes we found that there 
is a great variability and dispersion (graphic 2). When analysis was done regarding 
the CFRT, we found that, although the majority of CFRT did not vary much, there 
was a great SFCT variability (graphic 3). 
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Graphic 1 — Diabetic group — Distribution of SFCT 
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Group 2 — Control 
Baseline demographics for generic, systemic and non-retinal or choroidal variables 
are shown in tables 12 and 13.  
Variable n (eyes) Mean Std. Dev. Min Max 
age 78 58.5 14.0 21 85 
Gender (F/M) 78 44 (56.4%) / 34 (43.6%) 
VA 78 21.5 4.6 20 40 
RE 78 0.7 1.1 -2 3.75 
SBP 62 135.3 20.1 102 199 
DBP 62 78.4 12.9 52 114 
OP 78 14.7 2.9 10 24 
Table 12 — Demographics of Control group (analysis per eye). 
Legend: Gender — F- female, M- male; VA — visual acuity; RE — refractive error; SBP — systolic blood 
pressure; DBP — diastolic blood pressure; OP- ocular pressure 
Variable n (subjects) Mean Std. Dev. Min Max 
age 39 58.1 14.0 21 85 
Gender (F/M) 39 24 (61.5%) / 15 (38.5%) 
SBP 31 133.6 18.4 102 191 
DBP 31 76.9 12.1 52 111 
Table 13 — Demographic of Control group (analysis per subject) 
 
There was a failure to register blood pressure for 8 patients. The patients with a 
visual acuity lower than 20/20 was due to mild cataract not interfering with imaging 
acquisition and enough quality for analysis. 
Data regarding SFCT and CFRT is summarized in table 14. 
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Variable Obs Mean Std. Dev. Min Max 
SFCT_V1 78 281.8 74.1 61.0 412.0 
CFRT_V1 78 258.3 26.7 173 309.0 
Table 14 — Control group — Choroidal and retinal thickness. 
Legend: SFCT - subfoveal choroidal thickness; CFRT - central foveal choroidal thickness. 
SFCT had a huge range of measurements varying from 61 to 412µ with a wide 
dispersion of values by age (graphics 4 and 5). We can observe that youngest ages 
had the higher SFCT values and that the lowest SFCT values were related to the 
oldest ages. Great variability was found primarily in the intermediate ages (40-70). 
 
Graphic 4 — Control group — Distribution of SFCT 
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Graphic 5 — Control group — Distribution/dispersion of SFCT for each included eye 
by age 
Baseline Analysis 
No statistically significant difference was found between OD and OS in both groups 
(diabetic and healthy) for ocular variables excluding retinal and choroidal features 
(tables 15 and 16). 
Variable n (eyes) Mean 
Std. 
Dev. Min Max 
p (Wilcoxon) 
VA — OD 100 22.3 5.2 20 60 0.431 
VA — OS 96 23.9 11.9 20 100 
RE — OD 100 0.30 1.24 -3.75 3.25 0.334 
RE — OS 96 -0.13 2.9 -2.5 3.5 
OP — OD 88 15.4 3.2 10 24 0.249 
OP — OS 86 15.5 3.5 10 27 
Table 15 — Diabetic group — Differences between eyes 
There were no statistically significant differences between OD and OS. VA- visual acuity; RE — refractive 
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Variable n (eyes) Mean 
Std. 
Dev. Min Max 
p (Wilcoxon) 
VA OD 39 21.7 4.6 20 40 0.317 
VA — OS 39 21.4 4.8 20 40 
RE — OD 39 0.61 1.08 -2 3.25 0.254 
RE — OS 39 0.72 1.18 -1.75 3.75 
OP — OD 39 14.7 2.7 10 21 0.611 
OP — OS 39 14.8 3.2 10 24 
Table 16 — Control group — Differences between eyes 
There were no statistically significant differences between OD and OS. VA- visual acuity; RE — refractive 
error; OP — ocular pressure; OD — right eye; OS — left eye 
Using the Shapiro-Wilk normality test, no normality was found for the variables in 
general and by group. Thus, non-parametric test was used to evaluate if there were 
statistically significant difference between the two groups. Statistically significant 
difference was found between control and diabetic group for visual acuity (mean 
±SD: 21.5±4.6 versus 23.3±9.5: p=0.010), systolic blood pressure (mean ±SD: 
135.3±20.1 versus 142.3±19.8: p=0.010), ocular pressure (mean ±SD: 14.7±2.9 
versus 15.6±3.3: p=0.018), and refractive error (mean ±SD: 0.1± 2.2) - table 17. 
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age 0.612 Mann-Whitney 
 
Gender 0.092 Fisher Chi-Square  
VA 0.0222 Mann-Whitney  
RE 0.0174 Mann-Whitney  
SBP 0.0461 Mann-Whitney 
 
DBP 0.2861 Mann-Whitney  
OP 0.0367 Mann-Whitney  
Table 17 — Statistical results comparing the 2 groups for statistical difference 
When comparing SFCT and CFRT between controls and diabetic no statistically 
significant differences were found (p > 0.05) — table 18. 
Variable p Test 
SFCT 0.2978 Mann-Whitney 
CFRT 0.1631 Mann-Whitney 
Table 18 — Comparison of SFCT and CFRT between the two groups. 
 
For group 1 of diabetic subjects there was no significant statistical difference 
regarding SFCT between the different stages of DR (Kruskal-Wallis; p=0.3459) and 
between the stage with or without ME (Mann-Whitney; p= 0.5184) - tables 19 and 
20.  
  Mean SD Min Max 
DR = 0 264.32 81.08 96 495 
DR = 1 262 65.60 113 391 
DR = 2 265.64 85.46 100 423 
DR = 3 336.75 55.57 268 404 
Table 19 — SFCT mean values by diabetic retinopathy (DR) stage. 
Legend: 0= No DR; 1= mild non-proliferative DR; 2= moderate non-proliferative DR; 3= severe or 
proliferative DR. 
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  Mean Std. Dev. Min Max 
ME = 0 266.26 77.27 96 495 
ME = 1 262.81 85.10 100 461 
Table 20 — SFCT mean values by presence of macular edema (ME) 
Legend: 0= no ME; 1= with ME. 
In order to study the impact in Group 1 of the variables CFRT, contour, layers, 
HbA1c, duration of Diabetes, SBP, DBP, BP medicated, refractive error, VA, DR 
stage, age, and OP with the variable SFCT, a linear regression model was performed 
with the variable SFCT as a dependent variable and the remaining variables as 
independent variables (table 21). 
The model obtained is statistically significant (p < 0.001) and explains about 40% of 
the variance of SFCT (R2 = 0.402). 
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-0,11 0.17 -0.65 0.519 -0.44 0.22 
contour 
-13.21 13.83 -0.96 0.341 -40.59 14.17 
Layers 
-28.76 13.32 -2.16 0.033 -55.15 -2.37 
HbA1c 
-5.32 4.08 -1.3 0.195 -13.41 2.77 
Diabetes 
duration 
0.42 0.73 0.57 0.569 -1.03 1.87 
SBP 
0.01 0.38 0.01 0.989 -0.74 0.76 
DBP 
0.31 0.54 0.57 0.569 -0.77 1.39 
BP med 
25.28 15.02 1.68 0.095 -4.46 55.01 
RE 
-1.02 2.35 -0.43 0.666 -5.67 3.63 
VA 
0.17 1.29 0.13 0.896 -2.38 2.72 
DR stage 
19.09 12.15 1.57 0.119 -4.97 43.16 
ME 
-32.99 27.68 -1.19 0.236 -87.83 21.84 
Age 
-3.74 0.62 -6.0 0.000 -4.97 -2.51 
OP 
0.29 1.82 0.16 0.874 -3.32 3.90 
_cons 
511.26 70.94 7.21 0.000 370.75 651.77 
Table 21 — Multivariate analysis with SFCT as the dependent variable — Diabetic 
group 
Legend: Contour — sclero-choroidal border morphology (normal or abnormal); layers — choroidal layers 
(normal or abnormal); HbA1c — serum glycosylated hemoglobin; SBP — systolic blood pressure; DBP 
— diastolic blood pressure; BP med —medicated blood pressure; RE — refractive error; VA — visual 
acuity; DR stage — diabetic retinopathy stage; ME — presence of macular edema; OP — ocular pressure. 
A higher value of SFCT is significantly associated with abnormal layer morphology 
(p = 0.033). 
Considering the association found with age, the correlation obtained between SFCT 
and age (Spearman coefficient) is negative and moderate (r =-0.4667; p < 0.001). 
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For group 2, to study the impact of the variables CFRT, contour, layers, SBP, DBP, 
BP medicated, RE, VA, age, and OP with the variable SFCT, a linear regression 
model was performed with the variable SFCT as dependent variable and the 
remaining variables as independent ones (table 22). 
The model obtained is statistically significant (p < 0.001) and explains about 44% of 









CFRT 0.51 0.4 1.2 0.246 -0.4 1.4 
contour 9.85 24.1 0.4 0.685 -38.6 58.3 
layers -38.05 23.8 -1.6 0.116 -85.9 9.8 
SBP 2.24 0.8 2.8 0.007 0.6 3.8 
DBP -3.41 1.4 -2.5 0.017 -6.2 -0.6 
BPmed 22.12 17.7 1.3 0.218 -13.5 57.7 
RE -1.62 8.4 -0.2 0.847 -18.4 15.2 
ME 1.47 1.8 0.8 0.429 -2.2 5.2 
Age -2.38 0.8 -3.1 0.003 -3.9 -0.8 
OP -0.60 2.9 -0.2 0.838 -6.5 5.3 
_cons 220.54 161.5 1.4 0.178 -103.8 544.9 
Table 22 — Multivariate analysis with SFCT as the dependent variable — Control 
group. 
Legend: Contour — sclero-choroidal border morphology (normal or abnormal); layers — choroidal layers 
(normal or abnormal); SBP — systolic blood pressure; DBP — diastolic blood pressure; BP med —
medicated blood pressure; RE — refractive error; VA — visual acuity; DR stage — diabetic retinopathy 
stage; ME — presence of macular edema; OP — ocular pressure. 
A higher value of SFCT is associated with a higher value of SBP (p = 0.007), lower 
value of DBP (p = 0.017) and at a younger age (p = 0.003). 
Considering the association found with age, the correlation obtained between SFCT 
and age (Spearman coefficient) is negative and moderate (r =-0.424; p < 0.001). 
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Group 1, Diabetic 
85 eyes were analyzed for V2. 
The variables used for analysis of progression for the 2 consecutive visits were 
SFCT, CFRT, HbA1c, SBP, DBP, DR stage, and correlation with age and duration 
of Diabetes at baseline was looked for. 
No significantly statistical difference was found between the 2 visits for SFCT, CFRT 
and blood pressure. Significance was found for glycosylated hemoglobin, but it is not 
clinically significant (table 23). 
Variable Obs Mean 
Std. 
Dev. Min Max 
P 
(Wilcoxon) 
SFCT_V1 196 273.37 80.94 96.00 495.00 
0.1012 SFCT_V2 85 267.15 78.42 82.00 430.00 
CFRT_V1 196 270.55 45.94 209.00 517.00 
0.4828 CFRT_V2 85 272.31 50.24 197.00 568.00 
HbA1_V1 183 7.43 1.81 5.10 13.60 
0.0332 HbA1_V2 85 7.35 1.69 4.40 13.00 
SBP_V1 165 140.53 20.02 105.00 197.00 
0.0512 SBP _V2 85 134.41 17.38 98.00 193.00 
DBP_V1 165 76.35 13.65 45.00 132.00 
0.3896 SBP_V2 85 73.21 10.65 54.00 92.00 
Table 23 — Progression analysis — diabetic group. 
Legend: V1 — baseline; V2 — second visit. HbA1c — serum glycosylated hemoglobin; SBP — systolic 
blood pressure; DBP — diastolic blood pressure. 
There was a slight and non-significant decrease of SFCT from V1 to V2 (Wilcoxon; 
p=0.1012), with no correlation with the variables analyzed (table 24) 
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 SFCT_Dif CFRT_Dif HbA1_Dif SistBP~f DiastBP~f 
SFCT_Dif 1.000     
CFRT_Dif 0.224 1.000    
 0.089     
HbA1_Dif 0.034 -0.148 1.000   
 0.800 0.264    
SBP_Dif 0.089 0.005 -0.276 1.000  
 0.503 0.968 0.035   
DBP_Dif 0.113 -0.377 -0.003 0.687 1.000 
 0.393 0.003 0.984 0.000  
Table 24 — Correlation analysis between SFCT variation and CFRT and systemic 
variables — diabetic group. 
 
The variation of SCFT did not show any correlation with the duration of Diabetes or 
age (r =-0155; p = 0.158 for the duration of Diabetes, and r =-0.156; p = 0.155 for 




SFCT_Dif 1.000   
Years — 
Diabetes -0.155 1.000  
 0.158   
age -0.156 0.1713 1.000 
 0.155 0.1170  
Table 25 — Correlation of Variation of SCFT with duration of Diabetes and with age 
 
Comparison between the stage of DR from V1 to V2 for each eye was performed for 
the 85 eyes with a second visit. In V1 we had 61.9% eyes with grade 0 (no DR); 
23.8% with Grade 1 (mild NPDR); 10.7% with Grade 2 (moderate NPDR) and 3.6% 
with grade 3 (severe NPDR or PDR). In V2 we have 57.1% eyes with grade 0; 34.5% 
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with Grade 1; 4.8% with Grade 2 and 3.6% with grade 3. 79.9% of the eyes 
maintained the degree of DR from V1 to V2: 52.4% eyes with grade 0; 19% with 
grade 1; 4.8% with Grade 2 and 3.6% with grade 3. 
Statistically there was no significant variance (p= 0.0744: Stuart-Maxwell test) for the 
DR stage, and for Macular edema (p= 0.6547: McNemar test). 
The stage of DR was not analyzed for progression since very few patients had 
changes from baseline to V2. Four patients had a slight improvement in the DR stage 
(mild to no visible lesions). For Macular edema, 3 eyes with no ME at baseline had 
ME on V2. Eyes with macular edema at baseline were directed for treatment and 
dropped out from the study statistical analysis. The eyes with macular edema were 
analyzed individually for morphological changes (chapter 4.2.1). 
Group 2, Control 
14 eyes were analyzed for V2. 
The variables used for analysis of progression for the 2 consecutive visits were 
SFCT, CFRT, SBP, DBP and correlation with age at baseline was looked for. 
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Variable Obs Mean Std. Dev. Min Max 
P 
(Wilcoxon) 
SFCT_V1 78 281.8 74.1 61.0 412.0 
0.729 SFCT_V2 14 286.9 55.9 193.0 399.0 
CFRT_V1 78 258.3 26.7 173 309.0 
0.091 CFRT_V2 14 268.9 26.2 194.0 296.0 
SBP_V1 62 135.3 20.1 102.0 199.0 
0.664 SBP_V2 12 124.0 13.7 101.0 144.0 
DBP_V1 62 78.4 12.9 52.0 114.0 
0.875 DBP_V2 12 70.67 7.22 58.00 81.00 
Table 26 — Progression analysis — control group. 
Legend: V1 — baseline; V2 — second visit. SBP — systolic blood pressure; DBP — diastolic blood 
pressure. 
There was a slight and non-significant increase of SFCT from V1 to V2 (Wilcoxon; 
p=0.729), with no correlation with the variables analyzed (table 26). 
There was a negative and moderate correlation between the variation of SFCT and 
CFRT. However, this correlation was not statically significant (r =-0408; p = 0.188). 
No correlation was found between the variation of SFCT and age (r=0.130; p=0.657). 
(table 27). 
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 SFCT_Dif CFRT_Dif SistBP~f DiastBP~f 
SFCT_Dif 1.000    
CFRT_Dif -0.408 1.000   
 0.188    
SBP_Dif -0.286 -0.170 1.000  
 0.367 0.590   
DBP_Dif -0.332 0.220 0.070 1.000 
 0.291 0.490 0.820  
Table 27 — Correlation analysis between SFCT variation and CFRT and systemic 
variables — control group. 
 
To study the impact of CFRT variables (v2-v1), SBP (v2-v1), (v2-V1), age, and group 
(i.e., control or diabetic) with the variable SFCT (v2-v1), a linear regression model 
was performed with the variable SFCT (v2-v1) as a dependent variable and the 
remaining variables as independent ones (table 28). 
The model obtained was not statistically significant (P = 0.060) and explains about 
7.3 % of the variance of SFCT (V2-V1) (R2 = 0.0734). 
SFCT_Dif Coef. 
Std. 
Err. t P>t 
[95% 
Conf. Interval] 
CFRT_Dif 0.178 0.065 2.74 0.008 0.048 0.307 
SBP_Dif -0.042 0.229 -0.18 0.857 -0.499 0.416 
DBP_Dif 0.384 0.392 0.98 0.331 -0.398 1.165 
Age -0.411 0.317 -1.30 0.199 -1.044 0.221 
Group 10.511 9.117 1.15 0.253 -7.656 28.682 
_cons 21.378 18.900 1.13 0.262 -16.290 59.046 
Table 28 — Multivariate analysis of progression of variables with SFCT progression 
— control group. 
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The only factor associated with the variation of the SFCT is the variation of the CFRT, 
where a greater variation of SFCT is associated with a greater variation of CFRT 
(P=0.008) — graphic 6. But this association is weak (Spearman coefficient: r = 
0.0681; p = 0.5097).  
 
Graphic 6 — Correlation of progression of SFCT and CFRT — control group 
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CHAPTER 5 — DISSCUSSION 
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5 — DISSCUSSION 
The study included an important sample of patients that were followed for about two 
years. Its purpose was twofold: 
– to evaluate the correlation of choroidal features and changes with diabetic 
retinopathy and to identify possible markers of a diabetic choroidopathy in OCT 
images. 
– to find out whether choroidal thickness measurement could be considered alone 
as a reliable parameter for diabetic choroidopathy and if it could be related or 
justified by morphological findings in the choroidal structure. 
Very little was known about this at the beginning of the study. In order to avoid 
possible bias of choroidal changes caused by any diabetic retinopathy treatment 
such as laser and/or intravitreal injections, or other ocular treatments, since their 
effects on the choroid are still unclear, these were considered as exclusion criteria. 
Published data regarding possible effects of treatment on the choroid are unclear 
and disparate. While Ohara et al150 and Zhang et al151 described a significantly 
decrease in CT after pan retinal photocoagulation (PRP), Cho et al152 described an 
increase in CT after PRP. Kniggiendorf153 and Lains154 described a choroidal thinning 
following treatment with intravitreal Anti-VEGF. 
Since we considered previous treatment as exclusion criteria, most eyes included in 
this study were in earlier stages of the disease or had no diabetic retinopathy. In 
Portugal there is a National screening program for diabetic retinopathy that allows to 
evaluate, detect and treat almost all patients diagnosed with Diabetes by the family 
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Doctor and presenting diabetic retinopathy, most times in very early stages of 
diabetic retinopathy. It is not frequent to observe at the sub-speciality Retina 
consultation of the Ophthalmology department of an end-line treatment Hospital, 
more advanced cases of diabetic retinopathy with or without macular edema, but 
naïve of any treatment. 
Being an observational study with the intent to evaluate the natural course of 
progression, the follow-up visits were not planned with a restricted timing as it is 
done in clinical trials and were dependent on the appointment made by the family 
doctor and the health system gear. Thus, the follow-up visits interval varied a lot and 
many patients were lost of follow-up leading to an important decrease on the sample 
for ensuing visits.  
The study included both patients’ eyes except in situations where exclusion criteria 
were found in one eye. The inclusion of the two eyes was part of the principle that 
the changes to be studied were specific to each eye, independent of the contralateral 
eye. Thus, the non-ocular variables were presented demographically by patient (age, 
sex, SBP, DBP, HbA1c, Diabetes in years) while ocular variables were presented by 
eye (VA, RE, OP, SFCT, CFRT, contour, Layers, DR). The non-ocular variables were 
selected on the basis of previously published data that refer to a possible effect on 
choroidal thickness. Visual acuity, refractive error and ocular pressure were also 
recorded to have statistical data of possible effects on the choroid, but it was not the 
purpose of the study to correlate choroidal findings with visual function refractive 
error and ocular pressure. 
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Since one of the purposes of the study was to evaluate choroidal morphologic 
findings on OCT images, and few or almost none of these had been described 
previously in literature, we performed two pilot studies to define parameters for 
evaluation and comparison in the main study. In order to make choroidal thickness 
comparable with other publications, in this study we decided to register the sub 
foveal choroidal thickness for statistical analysis. However, variations in choroidal 
thickness along the scans were analyzed with the morphologic evaluation of the 
retina and choroid. 
It should also be noted that both graders for the OCT images (Lilianne Duarte and 
Miguel Ruão) had previously made an inter-grader variability study for choroidal 
posterior boundaries and choroidal thickness measurements with high agreement 
(unpublished data). The OCT devices used for this study had not a built-in software 
for automatic segmentation of the choroid boundaries, so this was done manually on 
the line scans. We could have tried to build a choroidal thickness map manually by 
doing segmentation of each scan of the cube protocol and slide the layers of the 
retinal thickness map, but this would be time consuming with great risk of slight errors 
of segmentation. Thus, in order to get superimposed thickness maps of the retina 
and choroid, we performed an ancillary study in collaboration with another Hospital 
with an OCT device that performs choroidal maps by automated segmentation. 
Only with follow up visits and images it is possible to evaluate if any findings found 
in a single visit change with progression of the disease with possible clinical 
meaning. Therefore, our study was designed as longitudinal, and morphologic and 
statistical analysis was made. Although some patients performed more than two 
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visits, the sample was too small to have significance, so we did the analysis 
comparing two follow-up visits. As far as we know, there is no other longitudinal study 
evaluating choroidal findings in diabetic patients. 
The outcome of our study shows that we can define normal morphologic features of 
the choroid layers and sclero-choroidal interface. With diabetic disease, changes in 
those morphologic features can be observed, classified, followed up and correlated 
with the retinal disease. Choroidal morphological changes occur focally related to 
the subjacent retina. Automated retinal and choroidal superimposed maps could be 
an easy way to identify focal zones to be evaluated for morphological changes. 
Statistical analysis showed a great variability and dispersion of sub-foveal choroidal 
thickness with an important variation susceptibility to different variables, turning into 
a low reliable parameter. Nevertheless, some significance was found between 
choroidal thickness in the correlation with age (decreases with age) for both groups:  
in Diabetics also with choroidal morphological changes (corroborating the 
morphologic study results) and in Controls also with blood pressure. 
For both groups, Diabetics and Controls, ocular but non-retinal or choroidal variables 
(VA, RE, OP), no statistically significant differences were found between OD and 
OS. These results give confidence in analyzing all eyes as separate subjects for 
retinal and choroidal findings. 
We compared the 2 groups (control and diabetic) regarding the non-retinal or 
choroidal variables, and using non-parametric tests due to the non- normality of the 
variables we found the following results: 
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– There were statistically significant differences between the two groups for: 
– VA — it makes clinical sense because the presence of pathology in diabetic 
eyes can interfere with the visual function; 
– SBP — Diabetic patients usually are with more morbidity, sometimes with 
kidney diabetic disease that can affect blood pressure control; and for RE 
and OP.  
– The statistical significance finding however, has no clinical relevance. In fact, if 
we look to the mean values, they have no clinical significance. 
Since there was no significant difference for age, sex, and refractive error, we can 
consider that the groups were similar for these parameters. 
The use of parametric tests is justified by the fact that most variables do not follow 
normal distribution within each group. Those considered statistically as normal are: 
age (only for diabetics); gender; refractive error (only for controls); DBP (only for 
controls); SFCT (only for diabetics); CFRT (only for controls). To avoid any bias in 
the statistical analysis, since some variables had normal distribution and others did 
not, we opted to use non-parametric tests, thus making the analysis more robust. 
When comparing both groups, there were no significant differences between SCFT 
and CFRT at baseline between the 2 groups (diabetic and control), but most of the 
diabetic (62%) had no retinopathy, being comparable to controls. 
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Nevertheless, besides the statistical result, we do have to look to the graphic for 
individual values to have the perception of the great variability of SFCT 
measurements by age or CFRT.  
Statistical Analysis of diabetics at baseline 
In our research, we found SFCT mean values of 273.8 µ ± 80.9 (range: 96-495 µ). 
When analyzing them by diabetic retinopathy sub-groups we found that the values 
were similar for NDR, mild NPDR and moderate NPDR, but higher in severe NPDR 
and PDR (respectively: 264.32 µ ± 81.08; 262 µ ±65.6; 265.64 µ ± 85.46; 336.75 µ 
± 55.57). In the cases of macular edema the value was 262.81 µ ± 85.10. As 
described previously in the literature review, mean values of SFCT in diabetic 
patients vary from studies. A great number of studies showed a decrease in SFCT 
with the severity of the diabetic retinopathy, while we found higher values in more 
severe stages, as described by Kim et al in a large sample study138. Our results can 
be biased since the number of eyes with more advanced disease was too small. 
However, like the results from all other published studies, what remains is the great 
variability or dispersion of SFCT measurements, which raises the question if mean 
value of a single sub foveal measurement is reliable. The choroidal thickness 
variability can be dependent on systemic, individual or pathologic conditions. 
Campos et al155 and Melancia et al156 made important reviews concerning 
publications somehow controversial results regarding choroidal thickness in 
Diabetes. As referred by Campos et al, published studies could not be entirely 
comparable for choroidal thickness since in they differ in terms of the design and 
variables analyzed. Some studies compared healthy patients with diabetic ones 
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without retinopathy127–131,138,142,157, and others compared healthy patients with 
diabetic ones with retinopathy disease and/or macular edema78,128,130,138,142,158,159. 
Increase, decrease or no change of choroidal thickness compared to healthy or 
related to the retinopathy stage can be found in the literature. Most studies are not 
longitudinal and are based in one single visit measurement. Few studies looked for 
correlation of choroidal thickness with other variables. 
In our study, when analyzing the impact of various variables on SFCT using the 
model of linear regression we obtained a statistically significant result (p=0.001) with 
a R2 of 0.4020 (it explains 40% of the SFCT variance). In other words, the fact that 
the model is significant means that the selected variables explain and can somehow 
predict the dependent variable (SFCT), and the value of R2 tells us that the model 
can explain a lot or a little. More than one third of the variable (SFCT) may be 
influenced by the remaining variables. When we look at the results of the model, we 
see that the variables that actually could explain or predict the dependent variable 
SFCT, are the ones that were significant i.e. layers (choroidal morphologic changes) 
and age, and the others end up explaining very little. The variable layers could be 
predictive since their significance level was of p= 0.033. Significance was also found 
negatively correlated with age. What these statistical results tell us is that, although 
SFCT can be influenced by various variables, the ones that have a significant impact 
are an increased thickness correlated to normal choroidal layers and decreased 
thickness with increasing age. No significant correlation was found with the central 
retinal thickness, which could be explained by the similar SFCT approximate value 
for eyes with macular edema comparing to the greater sample of eyes with NDR or 
initial stages. Most published studies regarding choroidal thickness in Diabetes do 
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not do a multivariate analysis to evaluate the impact of other variables in SFCT 
measurements. Few studies look for correlation with univariate analysis with 
metabolic state, duration of Diabetes, and age. The only consensual correlated 
variable is age with progressive decrease of thickness measurements. The choroid 
is a richly vascular structure with involving fibroblast and muscle meshwork. It is, 
therefore, expectable to have contractile or expansion (dilatation) response from 
these structures to physiologic and pathologic conditions, either ocular or systemic. 
On diabetic patients the metabolic state is altered frequently and associated to other 
morbidities such as high blood pressure. We do know from elsewhere in the body 
the vascular effect and damage of hyperglycemia and vascular changes with blood 
pressure disease. Nevertheless, in our study metabolic state and blood pressure, or 
duration of Diabetes could explain some variability but were not significant for 
correlation with SFCT. The same result was found for ocular variables except the 
choroidal ones. In their work, Xu et al157 also did a multivariate analysis and found 
correlation of SFCT with glycosylated Hemoglobin, age, diastolic blood pressure and 
the diagnose of Diabetes, but no correlation with the presence or stage of diabetic 
retinopathy. These findings also alert to the caution of using choroidal thickness 
alone as a parameter to determine the diabetic choroidopathy. 
Control Baseline Statistical Analysis 
We found for the control group mean SFCT values of 281.8 µ ± 74.1 (ranging from 
61 to 412µ). Our results are within the mean values of other studies in healthy 
population (table 1), but as described previously data vary tremendously from paper 
to paper. Control group also had a great variability in the SFCT values, as in the 
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diabetic group. Comparing with post-mortem data of choroidal thickness (± 220 µ) 
our mean choroidal thickness is slightly higher, but we should expect a thinning with 
histologic preparations and dehydration phenomena. Sohn et al in 2014160 published 
a histology study demonstrating a normal distribution of choroidal thickness but with 
a high range of thickness values, corroborating findings in published studies as well 
as in ours. Furthermore, it is expectable to have a multitude of variables that can 
interfere with the choroidal thickness measurement, even physiologic conditions.  
When analyzing the impact of other variables on SFCT the model obtained was 
statistically significant (p<0.001) explaining about 44% or more of the SFCT variance 
(R2 = 0.439). A positive significant correlation was found only with SBP and a 
negative correlation with DBP and age. The simple regression model gives us a ratio 
of SFCT decrease of -38µ/10 years. However, using a model of regression analysis 
taking into account the variables statistically significant (and considering SBP 
constant), then the ratio of loss falls to -23µ/10 years. The correlation of choroidal 
thinning with aging is the only consensual data from all studies, but the ratio for 10 
years varies from -11.8µ (Pappuru96), -13.1 µ (Shin103), -14 µ (Ikuno98), -15.6 µ 
(Margolis18), -19.5 µ (Ouyang101), -30 µ (Hirata99) to -33 µ (Wei104). These differences 
in the ratio might be justified by the fact that just few authors made corrections for 
statistically significant variables, and samples were very different in number, age and 
race (table 1). It is risky to establish a mean ratio of thinning with age since 
multifactorial factors can affect choroidal thickness. One of these factors can be 
blood pressure: in our study we found significance for systolic blood pressure. The 
choroid as a highly vascular structure can be sensitive to changes in systemic blood 
pressure. Few studies were published regarding the effect of systemic blood 
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pressure in choroidal thickness, but results are controversial. Akay et al161 and Ahn 
et al162 found a correlation of increased systemic arterial blood pressure with CT 
(with severe hypertension in the latter), but GöK et al163 conclude in their study that 
blood hypertension does not affect CT. Samson et al164 made a multivariate analysis 
in their study where they found a similar result to ours: a correlation only between 
systolic blood pressure with increased CT. Even if we still don’t know the real effect 
that blood pressure and blood pressure medication could have on CT 
measurements, it might be a confounding co-factor, especially if severe or 
uncontrolled. Other studies165,166 in healthy populations demonstrated diurnal 
choroidal thickness variability, by comparing morning to late afternoon 
measurements on the same individuals and the same day. 
Progression statistical analysis 
In the progression analysis there was no major or significant variation/progression of 
all variables, hence it is difficult to find correlations. The multivariate analysis of the 
impact of the other variables on SFCT was not statistically significant (p=0.060) with 
a R2= 0.0734 explaining only 7.3% of the variance. 
The only factor associated with the variation of the SFCT is the variation of the CFRT: 
a greater variation of SFCT is associated with a greater variation of CFRT (P = 
0.008). Considering the association found with SFCT (Spearman coefficient) this 
association is, however, weak (r = 0.0681; p = 0.5097). 
No publication was found with longitudinal data (sequential visits) for progression to 
compare with our results.  
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We did not find statistically significant data. Probably because most eyes in diabetic 
group were at the initial stages or even with no retinopathy, relatively well controlled 
metabolically, comparable to controls. Therefore, a mean of two year of follow up 
might be a too short follow-up period for disease progression evaluation. Moreover, 
with the “lost-to-follow-up” rate and the eyes dropped out for treatment, the sample 
decreased on the second visit. Data was in general almost the same for baseline 
and the second visit. Nevertheless, a weak correlation was found between the retinal 
progression and choroidal thickness change. 
Morphological Analysis 
From the pilot study we found differences in morphology of the choroid of normal 
and diabetic eyes, which allowed establishing a classification system of normal and 
abnormal that was used for the main study. The pilot study allowed suggesting that: 
– In healthy eyes, the SCI border tends to be regular, and has an inverted 
dome shape with the thickest point under the fovea; the ChS layer is regular 
and homogeneous with no focal invasion of great vessels 
– In diabetic eyes, this regular and homogeneous aspect tends to be 
disturbed, especially with progression of the retinopathy state, but it is in the 
presence of Macular edema that we can find a correlation between the 
choroidal morphological changes and the suffering suprajacent retina. 
Findings are: loss of the “inverted dome shape” and irregular delineation of 
the SCI, abnormal layers with loss of the integrity of the mottled ChS and 
parallel to the Bruch’s membrane, focal atrophy or increased thickness of 
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vascular layers, loss of even distribution, hyperreflective spaces on the 
vascular zone. 
Based on this normal and abnormal classification for SCI and Vascular layers, a 
morphologic analysis was made on the main study. 
For the healthy control group, we found that:  
– The ChS layer was always preserved (mottled, homogeneous with posterior 
limit parallel to the Bruch´s membrane 
– Most eyes had a normal SCI (inverted dome shape with thickest point sub-
foveal). When irregular it was always due to great vessels layer 
abnormalities. 
– Thinnest choroids in older subjects difficult evaluation. 
For the diabetic group we found that: 
– Half of the eyes had no morphologic abnormalities, probably, because most 
eyes had no DR or were at initial stages of DR. 
– When choroidal morphologic changes were found, they were particularly 
due to vascular changes than SCI changes, and primarily on the ChS layer 
and in eyes with DR. 
– Changes in the great vessel layers were the major responsible for the 
irregular sclero-choroidal border, usually due to focal atrophy or thinning, 
loss of vessels with hyperreflective spaces occupying the vessels space or 
hypertrophy. 
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– In the absence of evident retinal disease and changes in the 
choriocapillaris/Sattler’s layer, great vessels layer abnormalities are usually 
caused by focal loss or atrophy, more frequently nasal to the fovea, or loss 
of even distribution. 
– The changes on the choriocapillaris/Sattler’s layer such as focal 
atrophy/loss with approach of the great vessels to the Bruch’s membrane 
and hypertrophy associated with focal thinning or loss of subjacent great 
vessels, are correlated to the changes in the retinal anatomy above them. 
This becomes more evident in the presence of macular edema, specially, if 
the photoreceptor layer is affected. 
Only two published studies (Branchini148 and Adhi143), were done looking for 
morphologic findings of the choroid, using cross-sectional OCT images. The first 
study was carried out in healthy patients and findings compared with eyes with 
pathology such Age Macular Disease. The results of their study were used as a 
classification reference for our pilot studies. The second was performed in diabetic 
patients compared with healthy controls. This study has various similarities with ours. 
As parameters to evaluate choroidal morphologic changes were defined: the 
choroidoscleral interface could be regular, convex or bowl shaped (normal) or 
irregular or “S” shaped; they considered as normal if the thickest point of the choroid 
was sub-foveal (beneath the fovea or 100µ nasal or temporal); focal thinning of 
choroidal thickness was considered whenever the thinning was 50% less than the 
mean value in healthy (previously established) at the same location. However, for 
vascular analysis, a cut-off value was established for the diameter of large vessels 
(> 100µ). The large sub-foveal vessel and thickness measure from the anterior to 
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choroidoscleral limits of the vessel were identified in order to determine great vessels 
layer thickness by subtraction from the total SFCT, and consequently the Sattler and 
choriocapillaris layers. An irregular contour of the SCI was found on more than 90% 
of the eyes with diabetic retinopathy but not in the healthy ones. In addition, a 
significant thinning in CT in the Sattler and choriocapillaris layers in advanced stages 
of DR and Macular edema was found. 
The results of our morphological study are in accordance with the results of the 
studies mentioned above. However, in those studies, the morphological and vascular 
analysis was performed only at the subfoveal location. The method used in those 
studies for vascular analysis using mean values extrapolated from central 
measurements do not identify focal extra-foveal changes in choroidal morphology.  
The authors do not do a direct correlation of the focal choroidal changes with the 
retina above. It is a retrospective of one visit analysis with no data regarding 
progression of the findings. A number of patients were previously treated, so we 
cannot be sure if some findings could be a consequence of the treatment performed. 
Other studies167–169 looking for choroidal morphological findings on OCT used on the 
other hand, En-face images. In our point of view, those studies had some limitations, 
since the choroidal layers were identified by pre-determined thickness slabs based 
on mean thickness values previously established. If we take into account that there 
is a great variability in thickness of the choroid in healthy patients, and if in pathology 
the layers become irregular, we can predict artifacts on the evaluation. Nevertheless, 
Murakami et al168 found that diabetic eyes had more frequently than controls groups, 
areas without definite vascular structures in Sattler’s layer, focally narrowed vessels 
CHOROIDAL THICKNESS AND MORPHOLOGY ANALYSED BY OPTICAL COHERENCE TOMOGRAPHY AS A 




and vascular stump in Haller’s layer. But, statistically, they found no association of 
morphological changes with CT. 
Our findings are particularly interesting in that they suggest a response of the choroid 
to the retinal disease where it seems that to more acute stages a functional choroid 
respond increasing the blood flow to nourish the suffering retina, but later a diabetic 
choroidopathy occurs with ischemic, atrophic and other changes. Choroidal 
morphological changes seem to occur in a focal manner and only subjacent to the 
zone of the retina needing further nutrition and metabolic input. 
However, only with consecutive exams in follow-up visits we can validate if the 
choroidal morphological findings really may represent diabetic choroidopathy and its 
correlation with the retinal disease. In order to evaluate that, this study was designed 
as longitudinal research with follow-up visits, looking for progression on choroidal 
morphologic changes. We found that SFCT varied in subsequent visits despite the 
CFRT evolution. However, there was no evidence of any pattern or correlation of 
SFCT change (either an increase or a decrease) with the retinal thickness, although 
a great percentage of eyes with decrease in SFCT had also a CFRT decrease. Even 
when we stratified for severity of thickness change, no patterns were evident. SFCT 
should not be considered as a reliable parameter to evaluate progression or risk of 
progression, or a parameter to define severity or sequela of the retinal diabetic 
disease. 
From case to case analysis we found that focal changes in the retina tended to have 
subjacent choroidal changes. This may be explained by the theoretical assumption 
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of the choroidal function to support the retina, particularly the posterior layers. It 
seemed that, in some cases of retinal disturbances, there was a need to improve 
vascular and blood supply with a reactive or physiologic enlargement or dilatation of 
the great vessels pushed towards the Bruch’s membrane external limit and the 
retina. When the ocular diabetic disease becomes more advanced, the physiologic 
response of the choroid fails, and the choroid might start with Diabetes microvascular 
complications, with ischemic processes leading to focal areas of atrophy of the ChS 
layer and/or the great vessels layer, which corresponds on OCT images to the focal 
areas hyperreflective and/or atrophic. 
We know from histology that the choriocapillaris is organized in lobules as 
independent functional units with intervention on the retina immediately above, and 
only the choriocapillaris leak in the choroid. This may explain the correlation of focal 
retinal changes with the subjacent choroid found in our study. Even before the OCT, 
in histologic studies, Hidayat and Fine70, Fryczkowsky71 and Cao72 described a 
diabetic vascular choroidopathy with degeneration of the choriocapillaris with 
capillary dropout, basement membrane thickening, vascular abnormalities, such as, 
tortuosity, dilatation narrowing, microaneurysms and neovascularization. Cao et al. 
add that focal choriocapillaris degeneration is more initial and becomes diffuse at 
advanced stages associated with neovascularization.  
An interesting work of Zouache et al in 2016 demonstrates that the architecture of 
the choriocapillaris in independent capillary networks units, the lobules, are 
correlated with individual unit blood flow rates which can lead to localized 
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implications of the suprajacent retina function. This might be in agreement with the 
OCT findings of related focal choroidal changes with suprajacent retinopathy. 
In an excellent review of diabetic choroidopathy in 2017, Lutty et al170 postulate that  
inflammation and inflammatory cells might contribute to loss of choroidal 
vasculature. This was based on previously demonstrated accumulation of 
macrophages and PMNs in the retinas of diabetic rats. From histology and 
histochemistry there is evidence of a Diabetic choroidopathy that somehow leads to 
morphological changes in the choroid. 
Querques et al142 postulated a mechanism to explain how the choroid could be 
involved in the development of diabetic macular edema. They suggest that a 
decreased sub foveal choroidal thickness could cause tissue hypoxia with an 
increase in the level of VEGF, resulting in the breakdown of the blood-retinal barrier, 
responsible for the development of DR and macular edema145. 
The choroid has a completely different anatomy from the retina. While the retina is 
composed primarily of well-structured and organized cellular layers, with very little 
ability or property of changing size, the choroid is a highly and mostly vascular 
structure involved in connective tissue with high ability and property in changing size 
and thickness due to contractile and blood flow states. Thus, it is reliable to establish 
normal thickness values for the retina, since anatomically no extreme variability is 
expected at physiologic states. Moreover, even having choroidal thickness values 
from histology, on in vivo state, it is highly susceptible to physiologic influence, be it 
ocular or systemic, with a high variability of measurements. Thus, thickness 
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measurement only makes sense if correlated with morphology and analyzed 
individually and focally in subsequent visits.  
From our findings, focal morphologic changes in the choroid were correlated with 
focal changes in the retina. We made an ancillary study to evaluate if superimposing 
automated OCT retina thickness maps with choroid thickness maps would allow us 
to quickly localize focal areas of choroid morphologic changes correlated with the 
retinal disease. Our results demonstrated that we can superimpose retinal changes 
with choroidal changes using the maps and easily identify the focal zone to evaluate 
for morphological choroidal changes in line scans. Normal eyes showed the same 
pattern of choroidal thickness map as described in previously published 
studies99,101,106–109,128,131,133. They showed a continuous decrease in thickness from 
the superior, to temporal, to inferior to the nasal macula — the STIN pattern. In 
diabetic eyes different patterns of maps were found, with evidence of changes in the 
choroid even in early stages of DR. These results should be validated with a larger 
sample study. Unfortunately, till now, only one commercially available OCT (Topcon 
SS OCT) device has a software for automated choroidal thickness maps. With all 
the other OCTs available, we can build a choroidal thickness map doing choroid 
segmentation manually for each scan of the macular cube. This procedure is time-
consuming with great probability of segmentation errors in different scans, becoming 
not reliable or feasible. 
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Our study has some limitations or weaknesses. 
The classification used to define choroidal morphologic findings is dependent on 
quality and resolution of OCT images to allow good identification of SCI border and 
vascular abnormalities. In most available OCT devices, automatic SCI limit 
segmentation is not an option and becomes dependent on the training of the grader. 
When the choroid is very thin it is impossible to evaluate all the parameters described 
as to be evaluated for classification. Even with our simple classification, in some 
cases it is not easy to identify the choroidal findings or boundaries. A very clear 
definition needs to be made. Huynh et al.171 made a review looking to the posterior 
boundaries of the choroid in several studies and found some variability and lack of 
clarity in the definition of the exact choroidal scleral interface, leading to the variability 
in choroidal thickness measurements. They propose a harmonization classification 
and suggest that, for choroidal thickness measurements, the posterior boundary 
should be considered as the end of the choroidal vessels. Nevertheless, they advise 
that the suprachoroidal layer should also be measured, since it can have clinical 
relevance in pathology.171 
In our study we have done statistical analysis only for subfoveal choroidal thickness, 
although we demonstrate that changes in thickness occurs focally, sometimes extra-
foveal. Using only the central value for statistical analysis can leave out important 
thickness changes to be taken into account in the statistical data. But this is a 
limitation of all published papers, and our study was designed so as to be 
comparable with other studies. 
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In order to avoid the possible bias of the results, the inclusion/exclusion criteria were 
very strict, and only treatment-naïve eyes were allowed. Although we had a very 
good sample of eyes, the distribution by diabetic retinopathy severity groups was not 
equitable. There was a predominance of eyes with no or initial stages of DR, and 
therefore, less probability to have pathologic changes. Very few eyes had advanced 
stages and a small sample had macular edema. These were the ones that showed 
more prominent choroidal changes in the pilot studies. 
One of the main purposes of our study was also to evaluate progression, but the 
sample was too reduced for follow up visits. With the advance of the diabetic disease, 
a longer follow-up period may be needed to better evaluate progression. 
To our best knowledge, our study is the first to identify choroidal morphologic 
changes and correlate them with the retinal disease above. We were able to 
evidence very clearly in the morphologic progression analysis that there are 
choroidal morphological changes related to the retinal state, that can evolve to 
recovery or sequela, according to the severity of the disease. We think we 
demonstrated that statistical analysis of mean choroidal thickness, especially the 
central or subfoveal (mostly used is studies) is not a very reliable parameter to 
evaluate diabetic choroidopathy. However, even in the statistical analysis we found 
correlation with choroidal morphologic changes corroborating the argument that the 
choroid should be analyzed first for morphologic findings than for thickness. Our 
study was the first to introduce as a variable in the statistical analysis the 
presence/absence of morphologic changes in the choroid.  
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Based on our findings we propose a schematic module of physiologic and pathologic 
events occurring in the choroid. 
NORMAL CHANGES IN CHOROIDAL THICKNESS — PHYSIOLOGIC RESPONSE 
Changes in thickness respects the normal anatomy of the choroid, maintaining the 
inverted dome shape with the thickest point sub-foveal, integrity and homogeneity of 
the choriocapillaris and Sattler layers. Thickness changes are due essentially to 
physiologic vasodilatation and vasoconstriction, and it is reversible. 
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Figure 35 — Schematic and OCT image of normal choroidal morphology. 
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Figure 36 — Schematic image of normal choroidal morphology with vasoconstriction 
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Figure 37 — Schematic image of normal choroidal morphology with vasodilatation 
 
ABNORMAL CHANGES IN CHOROIDAL THICKNESS — PATHOLOGIC 
RESPONSE 
Changes in choroidal morphology with pathologic findings. Focal increase or 
decrease in thickness causing irregular contour with loss of the inverted dome shape. 
Focal changes in thickness are correlated with increased vascular caliper and 
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invasion of adjacent vascular layer (great vessel into the ChS layer or vice-versa), 
atrophic vascular layers and/or disappearance of vessels. 
 
Figure 38 — Schematic image of normal choroidal morphology 
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Figure 39 — Schematic and OCT image of an abnormal or pathologic choroidal 
morphology 
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Since most morphologic changes in the choroid are vascular, the best way to prove 
and evidence those changes would be with choroidal vascular architecture maps 
and flow data. 
More recently, with the OCT-Angiography, it has been is possible to obtain 
angiographic visualization with higher resolution of the vascular architecture (at 
capillary level) in a noninvasive manner with no dye. 
Some studies looking for vascular index and with OCT-angiography have been 
performed and published, and this could be the future complement to better 
understand the Diabetic choroidopathy133,172–175. 
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CHAPTER 6 — CONCLUSION 
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6 — CONCLUSION 
1 — We were able to identify morphologic parameters to be evaluated for 
normality or abnormality in OCT images of the choroid, allowing a simple 
classification system, achievable with any commercially available OCT device and 
software. 
2 — With diabetic retinal disease we demonstrated the evidence of a Diabetic 
choroidopathy directly correlated with the retinal disease above, and that changes 
occur focally, in accordance to data previously described in histology. 
3 — Choroidal thickness alone, as a mean value or one-point measurement is 
not reliable for analysis. Choroidal thickness changes should be analyzed and 
validated individually, in a map, correlated with choroidal morphologic changes and 
in subsequent observations. 
4 — The software of currently available OCT devices should be improved to allow 
automated and reliable choroidal segmentation and automated choroidal thickness 
maps. 
5 — Diabetic choroidopathy can be identified with OCT images, and signs of the 
disease could predict eventual progression, or regression with treatment, which 
could have some prognostic clinical value in ocular diabetic disease. More consistent 
data will be surely available, in the near future with the advances in OCT technology 
such as OCT-Angiography. 
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6 — We are the first, to our knowledge, presenting a longitudinal study in Diabetic 
choroidopathy using OCT images, where we were able to find that morphological 
changes in choroid occur related to the progression of the subjacent diabetic 
retinopathy. 
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